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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
Modified live virus (MLV) vaccines containing attenuated strains of virus are 
administered to provide protection against many different diseases. Modified live viral 
vaccines elicit both humoral and cell mediated immune responses and usually provide long 
term protection against disease. Inactivated viral (killed virus, KV) vaccines induce 
primarily humoral immune response that provide disease protection of a shorter duration 
than MLV vaccines. Killed virus vaccines are considered to be safer to use than MLV. With 
MLV vaccines there exists the risk that the attenuated viruses present in the vaccines may 
revert to virulence or that viral contaminants may be inadvertently introduced into the 
vaccines. Those risks are not present in KV vaccines that contain only killed components, as 
all ingredients are inactivated during the manufacturing process. 
The U.S. veterinary vaccine manufacturers are regulated by the United States 
Department of Agriculture (USDA) and follow high quality standards to assure that 
veterinary vaccines are pure, safe, potent, and effective. Those standards apply to all 
veterinary vaccines produced in the U.S. whether KV or MLV or produced for inter or intra 
state shipment. As part of the veterinary regulatory licensure process, strict guidelines for 
use of each vaccine are established and incorporated as label claims. The restrictions noted 
on the label claim include the species, age, and breeding status. It has been recognized that 
pregnant animals may be more susceptible to MLV vaccines and unless proven otherwise, 
label claims specifically exclude pregnant animals fi-om the recommended use. In addition, 
there have been multiple recommendations fi-om the scientific community to not use MLV 
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vaccines in pregnant animals, but often MLV vaccines are used as boosters to pregnant 
animals during middle to late gestation to induce high antibody titers so that colostral 
antibody transfer to neonates is optimized. 
The objectives of these studies is to describe the investigation of the virus isolated 
from several field cases of pregnant bitches that aborted following vaccination with a 
modified live, four component USDA licensed canine vaccine and the subsequent discovery 
of a bluetongue virus (BTV) contamination in that vaccine. This is the first association of 
BTV with disease in dogs. The association of abortion and death with BTV is further 
evaluated in pregnant bitches and evidence of cell culture adapted BTV as the cause of 
abortion is determined. The final study investigates the role of cell culture adapted BTV on 
non pregnant dogs and non pregnant sheep. That study determines if there are any acute 
consequences to administration of cell culture adapted BTV to non pregnant dogs and if this 
cell culture adapted bluetongue virus could potentially be spread to and cause infection or 
disease in sheep. 
Dissertation Organization 
This dissertation is organized in the style of separate manuscripts. Three manuscripts 
are included and represent chapters 2 through 4. Separate references are therefore included 
for the literature review and the 3 chapters. The first manuscript, chapter 2, "Abortion and 
death in pregnant bitches associated with a canine vaccine contaminated with bluetongue 
virus," has already been published and was written as a case report published in the Journal 
of the American Veterinary Medical Association and therefore does not include an abstract. 
The subsequent papers. Chapters 3 and 4, are intended as research reports for submission to 
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the American Journal of Veterinary Research and include abstracts. 
Literature Review 
Family Reoviridae 
The viral family Reoviridae consists of nine genera based on a similarity of structure, 
genome, and replication patterns. The genera in the family include, Cypovirus (cytoplasmic 
polyhedrosis viruses), Phytoreovirus (plant reovirus group 1), Fijivirus (plant reovirus 
group 2), Oryzavirus (plant reovirus group 3), Aquareovirus (golden shiner virus), 
Orthoreovirus (reoviruses), Orbivirus (orbiviruses). Rotavirus (rotaviruses), and Coltivirus 
(coltiviruses)."'^ Of these, the latter 5 are of human or animal disease importance. Viruses in 
the genus Aquareovirus are associated with viral diseases of fish. The reoviruses have been 
isolated from humans and animals^ and have been associated with disease in poultry and 
mice but not in other mammals.'* The orbiviruses are the cause of African horse sickness, 
epizootic hemorrhagic disease of deer, equine encephalosis, and bluetongue disease in 
ruminants. Diseases caused by the rotaviruses include diarrhea in human infants and 
enteritis in animals. The coltivirus genus includes the virus causing Colorado tick fever.^ 
The viruses in this family are characterized by a viral icosahedron shape, spherical, 
60-80 nm in diameter, and non enveloped. The outer shell consists of either a single or 
double outer protein coat and an inner protein capsid core. The double stranded RNA 
(dsRNA) genome consists of 10 to 27 segments, with the number of segments being 
characteristic for each genera. Replication occurs in the cytoplasm with inclusion body 
formation.^*^ Intact virions enter via receptor-mediated cell endocytosis while core viral 
particles without the outer coat (produced by enteric protease breakdown) may directly enter 
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the cytoplasm. In either case, the virus is degraded to a core particle prior to replication. 
Capping and transcription occurs on the 5' mRNA molecule via virion associated 
transcriptase and capping en2ymes. Initially only certain genes are transcribed, with the 
remaining genes being suppressed until early viral protein expression. Minus sense RNA is 
synthesized, forming dsRNA which is further transcribed forming additional dsRNA, but non 
capped. Translation of viral structural proteins occurs followed by viral particle self 
assembly. Release of virions occurs via cell lysis.'* 
The family was initially named in 1959 based on select members of the echo virus 10 
group that had been isolated from respiratory and gastrointestinal tracts, but had not been 
associated with any known diseases. The family was named based on the perception that 
these were "respiratory, enteric, orphan" (reo) viruses. Later the rotaviruses and orbiviruses 
were added to the group.^ 
Orbivirus genera 
The orbivirus genus is characterized by 10 segments of dsRNA. Virions have a 
poorly defined outer protein capsid when observed by electron microscopy using negative 
staining techniques,^® and are transmitted to animals in blood from arthropod vectors. Viral 
particles characteristically are 65-80 nm in diameter, disassociate the outer and inner capsid 
at moderate pH (< pH 5), are inactivated at low pH (< pH 3.0), are non infective at higher 
temperatures (> 60 C), and have a decreased infectivity following ether treatment.The 
orbiviruses have 7 structural proteins, identified as VPl to VP7 based on molecular weight 
on sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE).® The outer 
shell consists primarily of VP2 and VP5. VP2 is the primary antigen eliciting neutralizing 
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antibodies. The orbiviruses inner shell consists of 32 capsomers composed of 2 of the 7 
structural proteins, VP3 and VP7. VPl, VP4, and VP6 are found in the inner core in close 
association with the dsRNA. Antibody against VP7 is used to differentiate serogroups within 
the orbiviruses and VPS has been used for type specificity/'® The virus has 4 non structural 
(NS) proteins, NSl, NS2, NS3, and NS3A/'® These NS proteins are associated with viral 
mRNA, are the most abundant component of the granular viral inclusion bodies found in 
orbivirus infected cells, and are believed to be involved in initial virion assembly. NS3 and 
NS3 A are part of the viral release mechanism of orbivirus infected cells.® Bluetongue virus 1 
is the type species.^ 
The 10 segments of BTV are divided into 3 large RNA segments (LI to L3), 3 
medium (M4 to M6), and 4 small (S7 to SIO) based on migration patterns in PAGE gels.^ 
VPl is encoded by genome segment LI, VP2 by L2, and VP3 by L3. VP4 is encoded by M4 
genome segment, VPS by MS, VP6 by S9, and VP 7 by S7. NS 1 is encoded by M6, NS2 by 
S8, and NS3 and NS3A by S10.® 
There are 14 major serogroups recognized historically for the orbiviruses based on 
soluble antigens in complement-fixation, immunofluorescence, and/or agar-gel precipitation 
tests. Each of these serogroups have from 1 to 24 serotypes differentiated by serum 
neutralization. Recent genetic hybridization and sequencing studies have compared the 
homology of the various serogroups and have shown the previous serological groupings to be 
supported at the genomic level.' Similar studies done at the serotype level within several 
serogroups have shown that genetic reassortment has been a major factor in the evolution of 
distinct serotypes, but has not supported that reassortment occurs between serogroups.® 
The serogroups of economic importance in animals are bluetongue and African horse 
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sickness viruses. Bluetongue virus is endemic in North and South America, Africa, Middle 
East, Asia, and Australia and causes disease in sheep, cattle, goats, and deer. African horse 
sickness virus is endemic in Africa and there have been viral incursions into Spain and 
Portugal. African horse sickness causes disease in horses, zebras, and dogs.' Other 
orbiviruses of disease importance in animals are epizootic hemorrhagic disease virus (Avild 
ruminants and cattle), Ibaraki virus disease (cattle), and equine encephalosis (horses). 
Orbivirus infection in humans include Changuinola virus, Kemerovo complex viruses, 
Lebombo virus, and Orungo virus.^*® 
Transmission of the viruses occurs in various arthropod vectors including gnats, 
mosquitoes, phlebotomi (sand flies), or ticks. Replication of certain of the orbiviruses occurs 
in both the arthropod vector and in the vertebrate host. Normally no adverse effects are 
noted in the orbiviruses arthropod vectors, while in vertebrate hosts, disease can be 
inapparent to life threatening.^ 
Bluetongue virus 
Bluetongue virus, as the prototype species for the orbivirus genus, has been 
extensively studied. The outer capsid has been elucidated by cryoelectron micrographs and 
has been shown to have a well defined icosohedral symmetry of 860 A diameter. This is in 
contrast to the polymorphic symmetry depicted by conventional negative staining electron 
micrographs. The outer capsid proteins, VPS and VP2, have globular and "sail like" shapes, 
respectively. VPS proteins reside on each of the VP7 trimers that form the six-member rings 
of VP7 in the BTV inner core. VP2 proteins form spikes that sit above 180 of the 260 VP7 
trimers of the inner core and form 60 triskeletal-type motifs. VP2 trimers are believed to be 
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the serological hemagglutinating and neutralization antigens.'"'" 
The inner capsid is 690 A in diameter, of icosohedral symmetry, and has 260 knob 
like structures consisting of 780 VP7 units." The structure is organized into pentameric and 
hexameric units with intervening channels. The 132 resulting channels occurring at the 
three-fold axes have dimensions of approximately 70 A in depth and 80 A wide.'^ Additional 
work has shown that the inner capsid consists of 2 layers, an outer layer composed of VP7 
trimers and an inner layer composed of VPS monomers held to each other by hydrophobic 
interactions. At the three-fold axes small pores of 7 A diameter exist, while 9 A pores exist at 
the five-fold axes. The smaller pores are believed to be capable of enlargement by 
conformational change of the side chains, but are blocked by VP7. The larger pore at the 
five-fold axes can also be enlarged by conformational changes and may be the mechanism 
for movement of metabolites into the inner core for viral mRNA transcription and export of 
nascent mRNA fi-om the core.^''^ 
A subcore composed of VPl, VP4, and VP6 forms a lattice within the VP3 based 
inner layer. The NS proteins and the dsRNA are associated within the lattice and anchored 
to the VPS inner layer.'^"'^ The NS proteins are believed to elicit cell mediated responses."* 
In vertebrate erythrocytes, binding of BTV is to specific sialic acid containing, 
serine-linked, oligosaccharides in the glycophorins. This site is believed to be a receptor for 
both erythrocytes and other vertebrate animal cells.'' Binding to vertebrate cells is believed 
to be mediated via VP2 of the outer capsid. Binding to insect cells is believed to occur via 
VP7 following uncoating of the outer capsid.'® Entry into the cell occurs via receptor 
mediated endocytosis. Within an hour of entry the viral outer capsid is removed, and large 
translucent vesicles are formed and migrate close to the nucleus.Entry into the cytoplasm 
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occurs by penetration of the endosomal membrane and the binding to the cell cytoskeleton 
prior to initiation of viral transcription.'® The viral cores, composed of the irmer capsid, non 
structural proteins, and viral dsRNA, initiate viral translation and transcription. Those 
mRNA and proteins move through the viral pores into the cytoplasm, followed shortly by 
cellular sjmthesis inhibition.'® Virus specific polypeptides are detected within 2 to 4 hours of 
infection, peak at 11 to 13 hours, and slowly decrease until cell lysis occurs.^"*^' NSl forms 
tubules within the cjiloplasm. Bluetongue virus sub cores are initially formed (10 dsRNA 
segments, VPl, VPS, VP4, and VP6), VP7 is added to form the irmer core, and finally the 
outer core is added. A matrix forms around the core particles, composed of viral mRNA and 
virus specific proteins. Virus inclusion bodies are formed of BTV particles. The number 
and size of the viral inclusion bodies is dependent on the stage of infection, with inclusions 
bodies being maximized as viral replication peaks.^° The first two stages occur within ttie 
inclusion body. Final virion assembly occurs with the addition of the outer shell (VP2 and 
VPS) and occurs in close proximity to the inclusion body. The virion associates with the 
tubules, is transported to the cell membrane, associates with NS3/NS3A containing extra 
virion vesicles, and is released via cell budding, extrusion, or lysis.^^'^'* 
Presently 24 serotypes of BTV are recognized world wide. Serotypes of BTV 
isolates are determined based on serum neutralization (SN) studies using antiserum produced 
against whole virus. The SN techniques currently accepted by the Office International des 
Epizooties (OIE), the world organization for animal health, include plaque reduction, plaque 
inhibition, and microtiter neutralization." 
Bluetongue disease is historically a disease of ruminants. Sheep (especially 
European breeds), antelope, white-tailed deer, African antelope, and other artiodactyls are 
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the predominant species affected with clinical signs. Cattle and goats may occasionally 
show clinical signs.^"* Bluetongue was first recognized in South Africa over a hundred 
years ago and was described separately by D. Hutcheon and by J. Spreull in 1902.^® The 
disease was subsequently described in 1943 in Cyprus, but probably had occurred there since 
1924. Additional outbreaks in the Mediterranean region occurred in Israel in 1951, in 
Pakistan in 1959, and in India in 1963. Soremuzzle of sheep was described in 1952 in the 
United States of America (USA) and is believed to have originated in Texas as early as 1948. 
This was subsequently confirmed as being caused by BTV. Bluetongue virus was discovered 
in Portugal in 1956 and in Spain in 1957." Subsequently the virus has been foimd in most 
tropical and subtropical regions of the world. The initial concerns with BTV reflected a 
belief that BTV occiured only in epidemics and caused major economic hardships on the 
sheep industry. In the 1960s and 1970s BTV was considered an emerging disease, and 
intemational trade restrictions were placed on animal movement. Subsequently it has been 
shown that in sheep and cattle bluetongue is an endemic disease that occurs throughout the 
world without overt clinical disease.^' 
Transmission of bluetongue virus 
Bluetongue virus is not horizontally transmitted and vertical transmission via semen 
is rare. The primary means of infection is by bites of BTV infected midges of the Culicoides 
species. Culicoides spp. are found year round in tropical areas of the world. In sub tropical 
and areas adjacent Culicoides spp. are foimd on a seasonal basis.^® In sub tropical and 
adjacent areas the presence of Culicoides spp. varies and is dependent on temperature, wind, 
and moisture conditions. Many of the areas adjacent to sub tropical areas are free of 
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Culicoides spp. except from the middle of summer until first frost. Presence of Culicoides 
spp. and emergence of disease caused by BTV in the subtropical and adjacent areas are 
highly correlated to these factors. Disease is associated with increasing midge populations, 
and bluetongue has been reported to occur when frost free days exceed 100 days.^° 
Introduction of Culicoides spp. into areas normally free is believed to occur via wind bome 
movement of the insects.^' 
Midges become infected by ingesting blood of clinical or non clinical infected 
animals. Viral replication occurs in the salivary glands and highest concentration of virus 
occurs 6-8 days after ingestion. Subsequent biting of susceptible animals results in 
transmission.^' Midges remain infected indefinitely, but no transovarian passing of the virus 
to the insect's offspring occurs. Bluetongue virus is thought to be maintained in an endemic 
area by overwintering of the Culicoides spp. or by the subsequent reintroduction of the virus 
to midges by long term infected animals.^^ 
Bluetongue virus can be isolated from semen. Intrauterine transmission of BTV has 
been reported from semen from bulls infected naturally or experimentally.^"^ 
Bluetongue virus in the world 
Bluetongue virus serotypes 2, 10, 11, 13, and 17 have been found in North America 
and are principally transmitted by C. variipennis. Serotypes 1, 3,4, 6, 8, 12, and 17 are 
found in the Caribbean basin and transmitted by C. variipennis and C. insignis}^ Australia 
has 8 serotypes, serotypes 1, 3,9, 15, 16,20, 21, and 23 and the potential vectors are 
C. wadai, C. brevitarsis, C. actoni, and C. fulvis?^^^ Africa has 17 serotypes including 
serotypes 1, 2, 3, 4, 6, 10, 12 and 16 and the predominant vectors are C. imicola 
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(C. pallidennis), and C. milnei?^ The Middle East and Asia have reoccurring outbreaks, 
information on serotypes is sketchy at best, but serotypes 1 to 4, 7, 9, 10, 12, 16, 17, 20,21 
and 23 are believed to be present j&om all countries from Greece through Japan.^® Israel has 
reported serotypes 2,4, 6, 10, and 16 and Culicoides spp. C. imicola and C. obsoletus are the 
most important vectors. Malaysia has reported serotypes 1, 3, 9, 15, 16,20, 21, and 23 and 
up to 42 species of Culicoides spp. are potential vectors.^' 
Presently Europe is believed to be free of BTV but the presence of C. imicola 
provides for a potential vector if the virus is reintroduced.'*'' 
Distribution of bluetongue virus in North America 
Bluetongue virus is endemic in 30 states of the USA but is found rarely or not at all in 
the 18 northern and northeastern states, Alaska, and Hawaii. Serotypes 10, 11, 13, and 17 are 
found in those areas. Serotype 2 has not been found since 1986 and was only isolated in 
Florida and Alabama.'*' This distribution follows closely the climatological data for the 
USA, where incidence of BTV follows occurrence of 100 frost free days or more.'° 
Bluetongue virus in Canada has occurred only as incursions of BTV 11 from the USA 
and no endemic BTV is known to exist.'*^ 
Clinical disease and virulence mechanisms of bluetongue virus 
Bluetongue virus infection can occur in most ruminants, but disease typically occurs 
primarily in sheep and wild ruminants. Cattle become infected, have a prolonged viremia, 
but do not usually show clinical signs. Cattle play a significant role in the continuation of 
the disease and the endemic nature of BTV. Bluetongue virus can be detected in blood from 
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cattle for up to 38 days post infection by embryonated chicken egg inoculation and greater 
than 100 days using polymerase chain reaction (FCR) based detection."^' Most sheep also 
become infected without showing clinical signs. Sheep show both individual and breed 
susceptibilities. Breeds originating in the temperate regions are more susceptible than those 
of the tropical regions and older sheep are more susceptible than younger sheep.^®'"" In 
addition there are differences in the virulence of different serotypes of BTV and, at least for 
one serotype, difference in the virulence of strains of the same serotype when administered to 
cattle, although this study has not be replicated.'^^ Epizootics of disease occur in endemic 
areas, at the interfaces of endemic areas, and in areas where the virus is more episodic.^®''*^ 
When clinical disease does occur in sheep, it is characterized initially by difficult 
breathing and panting, hyperemia of the lips, muzzles, and ears, fever (up to 42 C), and 
depression. The dental pad becomes ulcerated and lameness may occur due to inflammation 
of the coronary band. Uncommonly, the tongue may turn cyanotic (hence the name for the 
disease, bluetongue). More progressive disease includes muscle necrosis, torticollis, 
vomiting, pneumonia, conjunctivitis and alopecia.^® Death normally occurs by pulmonary 
insufficiency due to exudate and hemorrhage that fills the lungs. Mortality in the USA is less 
than 10% compared to higher mortaUty reported for African serotypes. 
The pathogenesis of BTV infection in sheep includes initial infection via intradermal 
inoculation by a Culicoides spp. Replication is detected initially in tonsils, spleen, and 
regional lymph nodes followed shortly by viremia.''® Edema occurs due to viral damage to 
endothelial cells. Involvement of endothelial cells may be selective with a predilection for 
certain organs and for specific blood vessels.^^ Perivascular lymphocyte infiltration, 
microthrombi formation, and micro infarction occur throughout the body with severest 
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lesions occurring at the mucosal surface in striated muscle of the limbs and in the heart. The 
pathognomonic lesion for sheep is pulmonary artery hemorrhage.^'' In sheep, viremia is first 
detected 3-6 days post infection, peaks at 7-8 days and declines rapidly to day 14, and is 
rarely detected after day 30.^^ 
In cattle, BTV infection is predominantly asymptomatic. Initial infection occurs 
similarly to sheep with the lymphoid tissues being the first site of viral replication. The virus 
infects peripheral blood mononuclear cells and platelets, and transfer of the virus occurs via 
the lymphatic system. Secondary viral replication can occur in the spleen and lymph nodes. 
Additional mononuclear cells and erythrocytes become non preferentially infected. Virus 
infection of the cells of the blood system persists for the life of the cell. Although a prompt 
neutralizing immune response is elicited, the virus appears to sequester within the circulating 
cells, and virus can be detected for a period similar to the life span of the individual cell 
type.^^« 
Bluetongue virus has been reported with disease in pregnant sheep and cattle, 
however it apparently occurs very rarely. Strain differences have been noted that indicate an 
increased incidence for particular strains being more associated with infection of the 
pregnant uterus, embryo, and fetal infections, but has not definitively been shown to occur. 
Early embryonic deaths, abortions, and fetal malformations have been reported as resulting 
firom BTV infections. Association of BTV with temporary sterility and infertility in rams 
and bulls has also been suggested.^®*'^' Bluetongue virus shedding in semen has been 
documented and occurs while animals are viremic.^"*^' Bluetongue virus infections have not 
been associated with embryos collected during embryo transplant procedures if following 
adequate washing procediures.^^ 
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Diagnosis of bluetongue virus 
The identification of BTV as a cause of disease in sheep is initially based on clinical 
signs and presence of potential vectors. Disease in cattle and other ruminants is more 
problematic, not only due to the typical asymptomatic state, but also due to the confusion 
with other disease with similar clinical signs.^^ The definitive diagnosis of BTV infection is 
the isolation of virus from infected tissues. The classic laboratory technique for viral 
isolation is the intravenous inoculation of embryonated chicken eggs (ECE)," although cell 
culture inoculation on African green monkey kidney cells (Vero), baby hamster kidney, or 
Aedes insect cell line (C6-36) is possible, but the latter cell culture techniques have lower 
sensitivity for field isolates than the ECE inoculation.^^ The sample of choice for viral 
isolation from field studies is washed erythrocytes. Washing is necessary to remove the 
possibility of BTV antibody being present in the serum and blocking attachment and 
infection.^^ Altematively, the inoculation of sheep with large volumes via the subcutaneous 
route may be the most sensitive method. This technique is required for certification of 
imported fetal bovine serum into the USA, but has been replaced by the ECE inoculation for 
most field isolation studies.^'* Recently, various nested PCR based detection assays have 
been proposed for detection of both BTV and to serogroup samples. The PCR techniques 
have been shown to be more sensitive at detecting the presence of BTV than that of ECE 
inoculation,"^-^®'^^ but have the disadvantage of not resulting in an isolate of the virus. 
Detection of BTV in tissues sections is done by fluorescent antibody staining, 
immimoperoxidase methods,or by in situ hybridization.®'"®^ In addition to the recent PCR 
based methods for serogrouping and serotyping, the classical methods for identification are 
based on serological techniques. Immunofluorescence, antigen capture enzyme-linked 
15 
immunosorbent assays, and immunospot are group specific tests for BTV. For serotyping, 
classical viral neutralization tests are used and include plaque reduction, plaque inhibition, 
and microtiter neutralization, and are the techniques recognized by the Initially a 
complement fixation test was used to titer serum but was generally replaced by the agar gel 
inununodiffusion test. This latter test is now supplemented with a competitive ELISA 
(cELISA) test that has been shown to be more sensitive and able to differentiate serological 
response to BTV from epizootic hemorrhagic disease virus responses.^ 
Bluetongue virus in non ruminants 
Bluetongue virus historically has not been associated with infection and disease in 
animals other than ruminants. Subsequent to reports of BTV causing abortion and death in 
pregnant bitches following administration of a modified live canine vaccine contaminated 
with follow up surveys of carnivores have been conducted. A serological survey of 
dogs in Georgia found 1 of 40 dogs with serological BTV titers.®' The one dog had recently 
been vaccinated, but it could not definitely be shown whether that was with a potentially 
contaminated vaccine. A survey of black bears in Florida found 3 of 61 bears to be 
seropositive for BTV or epizootic hemorrhagic disease virus (EHD),'° a closely related virus 
to BTV.^^ A survey of carnivores in Africa found evidence of BTV antibodies.^' The 
authors speculate that possible routes of infection may include ingestion as is seen in dogs 
for Afiican horse sickness virus. 
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African horse sickness virus in dogs 
African horse sickness (AHS) is a disease of Equidae caused by another serogroup of 
the orbivirus distinct from the serogroup including BTV and also transmitted by Culicoides 
spp."'" Morphologically the virus is similar to BTV in size, shape, organization, and 
genomic segments/'* 
African horse sickness is considered endemic to Africa, primarily the sub Sahara 
region,^^"'^ with outbreaks occurring in Spain, Portugal, Yemen, and the Middle East/®'" 
The disease was first reported in South Africa in the 1700's and subsequently spread to other 
parts of Africa. 
The disease in horses presents in up to 4 different clinical syndromes, described as 
pulmonary, cardiac (or edema), fever, and a mixed form that is a combination of pulmonary 
and cardiac. The pulmonary form is characterized as being an acute, febrile disease with 
horses showing depression and anorexia which rapidly progresses to respiratory distress and 
death. The cardiac form is a subacute disease that presents as horses with fever, but lower 
than the pulmonary form, and swelling of the anterior-dorsal regions. Death occurs 4-8 days 
after initiation of clinical signs. The fever syndrome is a mild to subacute disease with a low 
grade fever presenting biphasically, typically in the afternoon. No other clinical signs are 
noted. The mixed form of AHS is found primarily at necropsy when both cardiac and 
pulmonary lesions are noted. Mortality for the pulmonary form is usually 100%, for the 
cardiac form 50-70%, and usually no mortality is associated with the fever syndrome. The 
mixed form has mortality between the pulmonary and cardiac forms. 
At necropsy, diffuse pulmonary edema with or without pleural effusion is found for 
the pulmonary form. Hydropericardium and petechial and ecchymotic hemorrhages of the 
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epi and endo cardium are found in the cardiac form along with edema of the affected portion 
of the body. No lesions are found in horses with the fever formJ® 
The pathogenesis of AHS is not well understood, but is believed to closely follow 
that of BTV with initial replication occurring in lymphoid tissues followed by dissemination 
via a viremic phase. A predilection for the endothelial cells and concurrent endothelial cell 
damage has been demonstrated,^" but replication is not at a high enough level to account for 
the AHS virus noted in horses.'^ Isolation from erythrocytes is possible, but classical 
techniques of cell culture isolation or newborn mice intracerebral inoculation'^ can be 
depended upon to isolate virus only during the early clinical, viremic time period.®' Recent 
studies using reverse transcription PGR have demonstrated virus association with 
erythrocytes from horses vaccinated with a subunit vaccine and then subsequently challenged 
with AHS. African horse sickness nucleic acid in these horses was detected by PGR for up 
to 22 weeks.®^ 
African horse sickness virus antibodies have been demonstrated to occur in multiple 
African mammals including cheetahs, lions, African wild dogs, jackals, hyenas, large-spotted 
genets, and domestic dogs. Lions and hyenas had the highest percent of animals positive.®^ 
The route of infection is believed to be via eating meat from animals infected with AHS. 
African horse sickness virus has been isolated from dogs in Egypt,^ and dogs experimentally 
infected with AHS via various routes, including ingestion, have been demonstrated to have 
AHS antibodies.®^ Early reports at the start of the twentieth century reported death in dogs 
from ingestion of AHS infected meat.^'*®^ A more recent study demonstrated that 13 of 17 
dogs consuming meat from a horse that had died from AHS died within 12 days. Two of the 
dogs were necropsied and showed generalized congestion and cyanosis. Those dogs had 
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severe diffuse pulmonary congestion and edema. The lungs were filled with exudate and 350 
ml of transudate fluid was recovered from the thoraxes. Virus consistent with AHS was 
recovered from both dogs.®' 
Viruses Associated with Abortion in Dogs 
Infective agents associated with abortion and still birth in dogs include bmcellosis, 
salmonellosis, streptococcal infection, toxoplasmosis, canine distemper, canine herpesvirus, 
and canine parvovirus-1 (minute virus of canine).®® Of the viral causes, canine herpesvirus 
infection®'"" and canine distemper'" have most closely been associated with transplacental 
infection and subsequent abortion in the dog. The remaining virus, canine parvovirus-1, has 
been associated with transplacental infection and abortion in experimental infection but has 
not been reported as a cause of abortion in clinical cases.®®*'^ Of the orbiviruses, only African 
horse fever has been historically associated with causing infection and there is no record of 
that disease being associated with abortion in dogs. 
Historical Viral Contaminants of Human and Veterinary Vaccines 
The possibility and source of viral contamination of vaccines is dependent on the 
method of production of the vaccine. When produced by either in vivo or in vitro methods, 
the starting virus (master seed) must be free of extraneous agents to assure that the final 
product is not contaminated. If produced in vivo from eggs or directly in or from animals 
each lot must be tested free from viral contamination or the herd or flock must be of knovm 
virus-free status. For veterinary poultry products this is assured by using eggs from flocks 
that are routinely monitored, tested, and known to be specific pathogen free. For processes 
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using mammalian animals, tissues, or fluids such a certification is also possible, but more 
typically products from such production methods are limited to product where inactivation of 
the viral product occurs. When producing vaccines using primary cells or continuous cell 
lines, contamination of the cells from the original tissue source, from nutrient supplements, 
or from animal origin components is possible. Testing to assiure that these ingredients are 
free of extraneous agents is part of production and quality control methods. In the USA 
specific requirements for testing are subject to governmental regulations and the required 
testing codified in the Code of Federal Regulation chapters 9 or 21 respectively, for 
veterinary and human vaccines.'^"'^ Certainly there is ample evidence of cell lines being 
found contaminated with viruses®®*'®^ that could potentially be a source for contamination of 
viral vaccines. 
Historically, failure to totally inactivate virus in killed viral products has occurred 
with killed rabies vaccines, killed foot and mouth vaccines, and inactivated polio vaccines. 
Contamination of in vivo produced vaccination materials has also occurred during small pox 
vaccination when using human lymph contaminated with syphilis.'"^ 
In more recent times the contamination of oral polio vaccines with simian virus 40 
from 1955 to 1961 resulted in the potential exposure of 98 million people in the USA to the 
virus. Studies are still ongoing to determine if adverse effects of the SV40 exposure have 
occurred in this population.'®"'"^ Other human vaccines reported to contain contaminating 
viruses are live polio, measles, mumps, and rubella vaccines contaminated with 
bacteriophages'"® and yellow fever vaccine contaminated with avian leukosis virus. 
Animal vaccines contaminated with extraneous viruses have included a 1950 
outbreak of Newcastle virus from live fowl pox and laryngotracheitis vaccine, a 1951 
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outbreak of fowl leukosis following the use of killed Newcastle disease vaccine thought to 
contain leukosis virus, and a 1956 report of visceral lymphomatosis virus in live Newcastle 
disease vaccines.'"® Additional contamination in poultry vaccines include the presence of 
reticuloendotheliosis virus in a Marek's disease vaccine'"'*"" and the potential contamination 
of multiple vaccines with chicken anemia agent virus.'" 
Additional techniques using PGR have been devised that suggest that the genome of 
various viruses are present in vaccines. This technique although useful for screening 
purposes, is sensitive to any viral genome present, whether from live virus or killed virus as 
would occur during processing of fetal bovine serum. Contaminants implicated have 
included bovine polyomavirus,"^ avian leukosis virus,wild type canine parvovirus,"'* 
pestivirus,"^""' and reverse transcriptase activity as an indicator for retroviral 
contaminants."® 
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CHAPTER 2. ABORTION AND DEATH IN PREGNANT BITCHES ASSOCIATED 
WITH A CANINE VACCINE CONTAMINATED WITH BLUETONGUE VIRUS 
A paper published in the Journal of the American Veterinary Medical Association" 
Linn A. Wilbur, DVM, MS;*" James F. Evermann, PhD;' Randall L. Levings, DVM, MS;'' 
lone R. Stoll;'' David E. Starling, DVM;'' Carol A. Spillers, OVM;** Gary A. Gustafson, BS;' 
Alison J. McKeiman, MS 
Two pregnant bitches, a 1.5-year-old Samoyed and a 2-year-old Golden Retriever, 
both in the last third of gestation, were vaccinated with a federally licensed, four-component, 
modified-live vaccine that contained canine distemper virus (CDV), canine parainfluenza 
virus (CPrV), canine adenovirus 2 (CAV2), and canine parvovirus (CPV) during a routine 
visit to a veterinary practitioner in Idaho. The vaccines were rehydrated with a killed 
coronavirus vaccine or a combination killed coronavirus vaccine/leptospira bacterin and 
were administered EM as a booster. Two days after vaccination, both bitches showed signs 
of depression and were febrile. Treatment with antibiotics was initiated. The Samoyed 
" Reprinted with permission of the J Am Vet Med Assoc, 1994, 204(11) 1762-1765 
'' Veterinary Biologies Laboratory, National Veterinary Services Laboratories, Veterinary Services, Animal and 
Plant Health Inspection Service, USD A, PO Box 844, Ames, lA 50010 
Washington Animal Disease Diagnostic Laboratory, College of Veterinary Medicine, Washington State 
University, PO Box 2037, College Station, Pullman, WA 99165 
Veterinary Biologies Field Operations, Biotechnology, Biologies, and Environmental Protection, Animal and 
Plant Health Inspection Service, USDA, 223 S Walnut, Ames, lA 50010 
' Diagnostic Virology Laboratory, National Veterinary Services Laboratories, Veterinary Services, Animal and 
Plant Health Inspection Service, USDA, PO Box 844, Ames, lA 50010 
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aborted 3 days after vaccination, and the Golden Retriever 4 days after vaccination. Both 
bitches continued to show signs of depression and became anorectic; the Golden Retriever 
remained febrile. Eight days after vaccination, the Samoyed developed dyspnea that rapidly 
became worse and resulted in death. The Golden Retriever failed to respond to antibiotic and 
supportive treatment, continued to show signs of depression, and remained anorectic and 
febrile. The Golden Retriever was euthanatized 9 days after vaccination at the owner's 
request. At necropsy, sanguineous pleural effusion, serous pericardial fluid, congested to 
hemorrhagic areas in the dorsal portions of the lungs, splenomegaly, enlarged mesenteric 
lymph nodes, and pale kidneys were observed in both dogs.^ 
Specimens, including 3 aborted fetuses from the Samoyed and selected tissues from 
both bitches, were submitted for histologic, bacteriologic, and virologic examination to a 
state veterinary diagnostic laboratory.® Histologic lesions were not observed in specimens 
obtained from the brain, lung, kidney, liver, spleen, and heart of the Samoyed fetuses. The 
placenta from the Samoyed had mild, focal, fibrinosuppurative vasculitis. Tissues from the 
Golden Retriever were observed to have severe diffiise glomerulonephropathy, moderate 
diffuse lymphocytic degenerative cardiomyopathy, severe centrolobular hepatocellular 
degeneration with centrolobular lymphocytic perivasculitis, and passive congestion of the 
lung. Neither specific organisms nor pathognomonic lesions were observed in any of the 
tissues. 
Bacteriologic cultures of the 3 Samoyed fetuses were negative for pathogenic bacteria 
after 72 hours of incubation. Placental tissues from the Samoyed had a large number of 
^ F. G. Hughbanks, Gooding, Idaho 
® Washington Animal Disease Diagnostic Laboratory, Pullman, Wash 
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bacteria, but pathogenic bacteria were not isolated after 72 hours of incubation. 
Bacteriologic cultures of tissues from the Golden Retriever were negative after 72 homrs. 
Results of viral isolation studies performed on pooled tissue specimens from the 3 
Samoyed fetuses were negative after 3 passages in Vero (African green monkey kidney) 
cells, Crandell feline kidney cells (CRFK), and Madin Darby canine kidney cells. Placenta 
and mesenteric lymph nodes from the Samoyed were found to contain a cytopathogenic 
agent after 3 passages in Vero and CRFK cells. Coronavirus-like agents were observed, by 
means of electron microscopy, in the intestinal contents from the Golden Retriever. Viruses 
that produced a cytopathic effect were isolated in Vero and CRFK cells from the lung and 
mesenteric lymph nodes of the Golden Retriever. 
The viral isolates were amplified by passage in Vero and CRFK cells. To aid in 
identification, the viruses were tested for chloroform susceptibility' and CPV 
immunofluorescence and infected cells were stained with H&E. The viruses were 
chloroform resistant, did not react with CPV reagents, and produced variously sized 
eosinophilic cytoplasmic inclusion bodies. The viral isolates were tentatively identified as 
members of the family Reoviridae. 
Because clinical signs developed following vaccination, the practitioner initiated a 
veterinary biologies consumer report with federal veterinary biologies regulatory officials.*" 
Identification of the isolates from the Samoyed and the Golden Retriever was requested from 
the laboratory supporting the federal veterinary biologies program.' Results of serum-
neutralization tests as well as direct and indirect fluorescent antibody examination of the 
^ Veterinary Biologies Field Operations, Ames, Iowa. 
' National Veterinary Services Laboratories, Ames, Iowa. 
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isolates were negative for viruses routinely associated with disease in dogs. The isolates had 
minor cross-reaction with a reovirus 1,2, and 3 polyvalent conjugate. Examination of 
electron micrographs of the isolate from the placenta of the Samoyed revealed a 60- to 70-
nm diameter, spherical, nonenveloped viral particle with 1 apparent capsid (Figure 1), 
tentatively identifying the isolate as an orbivirus of the Reoviridae family. Nucleic acids 
from this isolate were extracted with a chloroform-phenol procedure and compared to similar 
chloroform phenol extracted preparations of other representative members of the Reoviridae 
family, canine rotavirus,^ reovirus l,*" and bluetongue virus (BTV),' by means of 10.0% 
polyacrylamide gel electrophoresis (Figure 2)} The 10 gene segments and the genome 
migration pattem were consistent with the Orbivirus genus. The isolates reacted intensely 
with a fluorescent antibody conjugate for BTV. This conjugate is known to have limited 
cross-reaction with epizootic hemorrhagic disease of deer virus.™ 
Samples of the four-component, modified-live viral vaccine used in vaccinating the 
bitches were examined for viral contamination. Vaccine tested was from samples retained 
by the federal veterinary biologies regulatory agency. For all veterinary biologies, each 
production lot has a unique serial number and is individually tested by the manufacturer. 
Samples of each serial must be submitted to the federal veterinary biologies regulatory 
agency for storage in a veterinary biologies repository prior to the serial being approved for 
sale. Repository samples are randomly tested to confirm the manufacturers' test results and 
•' American BioResearch, 12621 N Milton Rd. Milton, Tenn. 
'' ATCC VR-230, American Type Culture Collection, 12301 Parklawn Dr. Rockville, Md. 
' Bluetongue serotype 17, courtesy of the Diagnostic Virology Laboratory, Ames, Iowa. 
Diagnostic Virology Laboratory, Ames, Iowa 
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Figure 1. Electron micrograph of virus isolated from the placenta of a dog that aborted and 
died after receiving a modified-live vaccine during late-term pregnancy (A) and of a virus 
isolated from a sample of the vaccine the dog received (B). Negatively stained with 1.0% 
phosphotungstic acid; bar =100 nm. 
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Figure 2. Migration pattern of viral genome segments on silver stained 10% polyacrylamide 
gel electrophoresis. Lane A = reovirus 1; Lane B = virus isolated from contaminated vaccine 
Lane C = virus isolated from a pregnant bitch that aborted and died after receiving the 
contaminated vaccine Lane D = bluetongue virus serotype 17; Lane E = canine rotavirus 
(second band is a doublet that resolved into 2 distinct bands when subjected to further 
electrophoresis). 
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are maintained to allow additional testing in the event of a consumer complaint. Two serials 
were known to have been purchased by the veterinary practitioner, but it was not known 
which of the serials was used to vaccinate the 2 bitches. Repository samples of each of these 
serials were reconstituted with sterile diluent, treated with chloroform to inactivate CD V and 
CPIV, neutralized with an equal volume of CAV2-specific canine antisera, and inoculated 
onto 75-cm^ flasks of Vero cells, known to be nonpermissive for growth of CPV. Flasks 
with cytopathic effect similar to that produced by the isolates from the Samoyed and Golden 
Retriever bitches were identified. Bluetongue virus was identified by means of further 
passage and fluorescent antibody examination. Virus was isolated from 1 of the 2 serials 
implicated by the veterinary practitioner. The cytopathic effect, ultrastructural 
characteristics on electron microscopy (Figure 1), genome electrophoretic pattern (Figure 2), 
and fluorescent pattern of the vaccine isolate were consistent with those expected with BTV 
and comparable to those of the isolates from the Samoyed and Golden Retriever. Further 
passages of the vaccine-inoculated cell cultures were negative for CDV, CAV2, CPIV, and 
CPV when examined by means of direct or indirect fluorescent antibody tests. 
Additional consumer reports were received from an Iowa veterinary practitioner. 
This practitioner first reported the death of 2 pregnant bitches, the abortion in and subsequent 
death of 3 other bitches, and the death of 5 pups and their dam following administration of 
vaccine by the dogs' owner. This practitioner later reported abortion in and death of 2 
additional bitches following vaccination by the veterinary practitioner. The vaccine 
associated with these reports was the same manufacturer's CDV, CPIV, CAV2, and CPV 
vaccine as those identified in the Idaho cases, but had a different serial number. The Iowa 
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practitioner submitted tissue specimens to 2 different diagnostic laboratories," and samples 
were subsequently submitted to the veterinary biologies regulatory laboratory.' Each 
specimen was suspended with an equal volxime (weight/volume) of tissue cultiure medium, 
homogenized with a tissue homogenizer," and centrifuged at 1400 X g for 20 minutes. The 
supernatant was chloroform treated and used to inoculate Vero cells. Flasks with cytopathic 
effect were passaged, and virus was identified as described for the other isolates. Isolates 
consistent with BTV were obtained from maternal liver, small intestine, large intestine, 
kidney, and spleen, but not from aborted fetal material. Repository samples of the associated 
vaccine serial were examined as described and found to be contaminated with BTV. 
Four additional cases have been reported. Three of these involved abortion and 
death, and the fourth, vaginitis. Viruses consistent with the previous isolates were obtained 
by methods similar to those described. These isolates were submitted to the veterinary 
biologies regulatory laboratory^ by the state diagnostic laboratory® and reacted with the BTV 
fluorescent antibody conjugate. In each instance, the vaccines used were different serials of 
the same manufacturer's vaccine, and repository samples were found to be contaminated with 
BTV. 
The viral isolate obtained from the repository sample corresponding to one of the 
vaccines implicated in the Iowa cases has been serotyped as BTV 11 with a plaque inhibition 
method (Figure 3).^ Serotype 11 is a domestic strain of BTV.'^ 
The veterinary biologic manufacturer was informed of the isolation of a viral 
" Animal Disease Research and Diagnostic Laboratory, South Dakota State University, Brookings, SD, and 
Veterinary Diagnostic Laboratory, Iowa State University, Ames, Iowa. 
° BCinematica Model 10-35, Brinkmann Instrument, Wesbury, NY. 
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Figure 3. Plaque inhibition test on McCoy cell line for serotyping viruses isolated from a 
contaminated vaccine. Serotype is indicated by viable cells (stained with neutral red) 
surrounding a disk following 3 days of incubation. Antisera directed against domestic strains 
of bluetongue virus (BTV) and epizootic hemorrhagic disease of deer virus (EHDV), another 
orbivirus known to cross-react with BTV, were used. Vaccine isolate was used to infect 
monolayer cell cultiure; paper disks were saturated with antiserum (counterclockwise) to 
BTV2, BTV 10, BTV II, BIV 13, BTV 17, EHDV I, EHDV2, and fetal bovine serum. 
contaminant. The manufacturer voluntarily recalled all vials of the vaccine with serial 
numbers the same as those associated with these cases. 
Bluetongue virus has not previously been associated with disease in dogs, but has 
been considered a disease of ruminants.^'® African horsesickness is caused by an orbivirus 
not found in the United States that is serologically distinct from BTV and is the only 
orbivirus previously associated with naturally occurring infection in dogs. African 
horsesickness virus has not been associated with abortion in bitches, but rather has been 
characterized as causing viremia with subclinical signs.^'^ 
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In the present report, a BTV contaminant given with a historically safe canine vaccine 
apparently caused disease when administered to late-term pregnant bitches. 
Recommendations to not vaccinate pregnant animals with modified-live vaccines, unless the 
vaccine is specifically approved for that use, have previously been made,'"'° and may be 
indicative of an increased sensitivity of pregnant animals and their fetuses to viruses." 
Additional case reports have been received implicating serials of BTV-contaminated vaccine 
with various disease syndromes in nonpregnant dogs, but viral isolation studies on tissue 
submissions, to date, have been BTV negative. 
Several veterinary practitioners associated clinical disease in dogs with recent 
vaccination and a nontypical virus was isolated from tissue specimens collected from 
affected dogs. The USDA's Veterinary Biologies Consumer Information Hotline (515/ 232-
5789) was used to inform the regulatory agency of adverse reactions associated with a 
licensed veterinary vaccine. That information was used to identify a suspect product and 
confirm contamination in associated vaccine serials; this resulted in these serials being 
recalled. Practitioners, diagnostic laboratories, the federal regulatory agency, and the 
veterinary biologic manufacturer worked together to remove a contaminated product from 
the market. 
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CHAPTER 3. ABORTION IN PREGNANT BITCHES FOLLOWING 
CHALLENGE WITH CELL CULTURE ADAPTED BLUETONGUE VIRUS 
A paper to be submitted to the American Journal of Veterinary Research 
Linn A. Wilbur, DVM, MS;^ Randall L. Levings, DVM, MS;" Jack C. Rhyan, D.V.M., M.S.;" 
lone R. Stoll;" James F. Evermann, PhD;"^ Ricardo F. Rosenbusch, D.V.M., Ph.D.'' 
Abstract 
A cell culture adapted bluetongue virus (BTV), isolated from a contaminated 
commercial modified-live 4-component canine vaccine, was administered by the 
intramuscular route to four pregnant bitches in mid gestation. The bitches were monitored 
and observed for 10 days. Elevated temperatures, vomiting, anorexia, depression, and 
vaginal discharge were observed. Three of the 4 bitches were observed to have aborted on 
days 4 to 6 after challenge. The remaining bitch was determined to have aborted when 
necropsied at the conclusion of the study. One bitch exhibited respiratory distress, another 
had a rapidly falling temperature after aborting and subsequently died v^thin 24 hours. 
Bluetongue virus was isolated from blood samples collected on days 1 to 9, with 
" Veterinary Biologies Laboratory, National Veterinary Services Laboratories, Veterinary Services, Animal and 
Plant Health Inspection Service, USD A, PO Box 844, Ames, lA 50010 
** Pathobiology Laboratory, National Veterinary Services Laboratories, Veterinary Services, Animal and Plant 
Health Inspection Service, USD A, PO Box 844, Ames, lA 50010 
Washington Animal Disease Diagnostic Laboratory, College of Veterinary Medicine, Washington State 
University, PO Box 2037, College Station, Pullman, WA 99165 
^ Veterinary Medical Research Institute, Iowa State University, Ames, lA 50010. 
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maximum viral titer obtained on days 3 to 5. Bluetongue virus was isolated from tissues 
from the 4 bitches and from fetuses from 2 of 3 bitches. The most consistent BTV isolation 
came from lung, spleen, and placenta of the bitches. One of 4 of the bitches seroconverted 
based on a commercial cELIS A diagnostic kit. The remaining 3 had rising cELIS A 
inhibition percentages, indicative of the early stages of an immune response. 
Following the administration of a cell culture adapted BTV, bitches became clinically 
ill, BTV was recovered during clinical illness, 3 of 4 of the bitches were observed to abort, 
and BTV was isolated from both maternal and fetal tissues. This study demonstrates that cell 
culture adapted BTV can cause clinical illness and abortion in pregnant bitches when 
iatrically administered. 
Introduction 
Bluetongue virus (BTV), the prototype virus for the genus Orbivirus^ is naturally 
transmitted to animals by various Culicoides spp. midges, and has historically infected sheep, 
cattle, and wild ruminants.^'^ Clinical disease occurs primarily in sheep. Cattle and wild 
ruminants, although infected, normally remain subclinical. Bluetongue virus has not been 
reported to be associated with infection and disease in non ruminants. 
Recently, abortion and death in pregnant bitches following use of a commercial 
modified live vaccine contaminated with a BTV have been reported.'*'® In those studies, the 
same serotype BTV was isolated from a multivalent vaccine and from various tissues of both 
bitches and aborted fetuses. Based on these isolations, an association with the clinical 
disease in these bitches was made. This study details the experimental infection of pregnant 
bitches with a cell culture adapted BTV obtained from the contaminated vaccine to show that 
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cell culture adapted BTV iatrically administered can conclusively be demonstrated as the 
cause of infection, viremia, and abortion in pregnant bitches. 
Materials and Methods 
Dogs 
Foiu* purebred female beagles were used in this study. Two bitches were obtained 
from a commercial dog colony and had only been vaccinated with a killed rabies product. 
Bitches were supplied as being in mid to late gestation based on date of last observed 
breeding. Two bitches were obtained from the National Veterinary Services Laboratories 
(NVSL) SPF dog colony and had never received any vaccinations. Bitches were housed in a 
climate controlled enviromnent in separate pens, 2 bitches per room. The floor of the pen 
was washed twice daily and the bitches were fed a commercial dry dog food supplemented 
with commercial wet food. Bitches within each room had fence line contact. Bitches from 
the commercial colony were wormed and treated for fleas upon arrival and a 21-day 
acclimation period was observed prior to initiation of the experiment. Bitches from the 
NVSL colony were locally moved and allowed to acclimate for 3 days. The experiment was 
conducted with the approval of the NVSL Animal Care and Use Committee in accordance 
with the NIH guidelines and the Animal Welfare Act. 
Challenge 
Bluetongue vims was isolated as previously described from a modified live, 
multivalent canine distemper, canine parvovirus, canine parainfluenza, and canine 
adenovirus-2 vaccine that had been associated with abortion and death in pregnant bitches.^ 
One additional passage in a baby hamster kidney cell line was used to expand the isolate 
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from the previous two passages in a Vero cell line. The challenge was examined for other 
contaminating viruses and bacteria by the methods described in Section 9 of the Code of 
Federal Regulations. The virus was diluted 1:10 in MEM without fetal bovine serum. The 4 
bitches received 1.0 ml of the challenge virus in 1 site on the rear leg by the intramuscular 
route using a 22-gauge 1 inch needle and syringe. 
Observation and sample collection 
Each bitch was observed twice daily starting a day prior to challenge (day -1) through 
day 10 post challenge. Rectal temperatures were taken and blood collected daily in tubes 
containing EDTA. Blood for serum was collected on days 0,4, 7, and 10 post challenge. 
Frequency of observation and recording of rectal temperatures was increased for all bitches 
as animals exhibited clinical signs. Clinical signs were recorded and bitches observed for 
abortion. Any aborted fetuses or bitch dying during the 10-day study was immediately 
necropsied and samples collected and frozen at -70 C for viral isolation. All surviviag 
animals were humanely euthanatized, necropsied, and samples for viral isolation collected 
and frozen at -70 C on day 10 post challenge. 
Blood samples 
Serum was separated from clotted blood by centrifiigation at 1,800 Xg- for 10 
minutes and stored at 4 C. A commercial BTV competitive ELISA (cELISA) diagnostic kit 
was used to determine BTV antibody levels." 
EDTA blood samples were centrifuged at 750 X g for 10 minutes and the serum 
removed. The RBCs were washed by suspending the RBC pellet in a voliune of 4 C sterile 
® Bluetongue antibody test kit, cELISA, Veterinary Diagnostic Technology, Inc.,Wheat Ridge, CO 80033 
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PBS equal to the removed serum volume and then centrifuged at 750 Xg for 15 minutes at 4 
C. The procedure was repeated for a total of 3 washes. The final washed RBC pellets were 
suspended with an equal volimie of buffered lactose peptone with 375 ng/ml gentomycin, 50 
|ig/ml kanamycin, and 50 ng/ml amphotercin B. The RBC suspension was maintained in an 
ice bath and sonicated for 3-1 minute cycles at 60 watts in a cup hom to disrupt the cells and 
release vims. 
RBC BTV titers 
Two fold dilutions of the sonicated RBC suspension, starting at 1:5 were made in 
MEM with 750 imits/ml penicillin, 75 imits/ml streptomycin, and 50 p.g/ml gentamycin. 
These were inoculated, 5 wells per dilution, onto confluent Vero cell culture using a 96-well 
plate format. Undiluted sonicated RBC solution had previously been shown be toxic to cells. 
The plates were observed daily under low power magnification for 7 days, wells exhibiting 
CPE recorded, and the end point titer determined by the method of Spearman and Karber as 
modified by Finney.^ 
Viral isolation from tissues 
Tissues were treated as previously described ^ substituting MEM media containing 
75 units/ml penicillin, 225 units/ml streptomycin, and 150 jig/ml gentamycin. Kidney, lung, 
spleen, liver, uterus, and placenta were individually examined from each bitch and each 
aborted fetus. Four hundred microliters (400 ^1) of supematant was inoculated onto 25 cm^ 
flasks of confluent Vero cell culture and 400 p.1 onto a 25 cm^ flask of embryonic bovine 
kidney (EBK) pr imary cel ls  for  each supematant .  Flasks  were  incubated a t36Cina5% 
COj incubator. Flasks were observed daily for CPE and frozen at -70 C when CPE was 
observed. Flasks not exhibiting CPE were subpassaged 2 additional times at 4-6 day 
47 
intervals. Flasks not exhibiting CPE at the end of the 2nd passage were considered negative. 
Positive CPE flasks were thawed at room temperature, centrifiiged at 200 X g for 10 minutes, 
and the supematent individually collected. Vero cell culture in 8 chamber glass slides, 24 
hours after inoculation and incubation at 36 C in 5% COj, were inoculated with 0.1 ml per 
chamber of the supematent and further incubated at 36 C in a 5% CO2 incubator. Slides 
were examined daily and fixed with acetone if CPE was evident or fixed at 7 days if no CPE 
was observed. Cells were examined using a direct fluorescent antibody BTV conjugate'^and 
an ultraviolet light microscope and considered a positive isolate if specific BTV fluorescence 
was observed. 
Results 
Challenge 
The BHK passaged BTV titered 7.3 logig tissue culture infective dose 50 (TCID50) in 
the Vero cell culture by CPE, resulting in a challenge of 6.3 TCID50 log,o for the 4 
experimental bitches after the 1:10 dilution. The challenge virus was shown to be free of any 
contaminating virus. 
Observations 
Clinical signs observed included vomiting, anorexia, depression, respiratory distress, 
vaginal discharge, and abortion (Table 1). Abortion was observed in 3 of the 4 bitches and 
on necropsy there was evidence that the remaining non aborting bitch (bitch 3) had been 
pregnant and recently aborted pups. Based on the cotyledon size these were judged to be 
^ Bluetongue fluorescent antibody conjugate. National Veterinary Services Laboratories, Ames, \A 
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Table 1. Days post inoculation at which clinical signs were observed for experimental 
bitches. 
Bitch 1 Bitch 2 Bitch 3 Bitch 4 
Abortion 6 4 n.o. 5 
Vaginal discharge 6-8 4-5 n.o. 5 
Respiratory distress 8-10 6-8 n.o. 5 
Depression 7-10 n.o. n.o. n.o. 
Anorexia 5-10 5-10 n.o. 4-5 
Vomiti^ 6,8 2 0, 1,9 3 
n.o = not observed 
early term fetuses. No aborted fetuses were observed from bitch 3, nor were clinical signs 
other than vomiting observed. One bitch (bitch 4) died on day 5, a day after aborting. 
Initially 1 pup was aborted and 4 were found to be still retained on necropsy for bitch 4. 
The bitches had clinically normal temperatures until day 3 post challenge, when 2 of 
the 4 bitches had temperatures higher than normal (Figure I). By day 4 post challenge all 4 
bitches had elevated temperatures. One of the bitches had a rapid decline in temperature 
from the time of abortion to death 24 hours post abortion. By day 8 post challenge 2 of the 3 
remaining bitches (bitch 2 and 3) had returned to within the normal range. The remaining 
bitch (bitch 1) remained febrile until the end of the 10 day post challenge obsen^ation period. 
Blood samples 
The percent inhibition in a cELISA increased dxxring the 10 day observation period 
(Figure 2). Only one bitch was positive at 10 days post inoculation when evaluated by the 
50% threshold value for ruminants. 
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Figure 1. Temperature of BTV challenge bitches for days -1 to 10 post challenge with time 
of observed abortions and death indicated. 
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Figure 2. Percent inhibition of serum from challenged bitches by a cELISA commercial 
diagnostic test kit for days 0,4, 7, and 10. Bitch 4 died on day 5. Greater than 50% 
inhibition is considered a positive antibody titer for bovines. No inhibition level has been 
determined for dogs. 
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RBC BTV titers 
Bluetongue viral titers obtained in Vero cell culture are reported in Figure 3. Viremia 
was evident from day I to day 9, with all 4 of the bitches being viremic by day 3. Peak titers 
occurred on day 4 and 5. Titers declined starting day 5 with the three surviving bitches being 
below detection levels by day 9. 
Viral isolation from tissues 
Bluetongue virus was isolated from all four of the bitches and from 2 of the 3 bitches 
aborting fetuses (Table 2). Bluetongue virus isolation was most consistent from lung, 
placenta, and spleen samples of the dams with the remaining tissues having sporadic 
isolation of BTV. 
Table 2. Viral isolation of BTV by tissue for challenged bitches and their aborted fetuses 
Bitch I* Bitch 2* Bitch 3* Bitch 4** 
Dam Fetus Dam Fetus Fetus Dam Fetus 
Lung + + + + + n/a + -
Liver 
- -
- + - n/a - -
Spleen + - + - + n/a + -
Kidney 
- - - -1- + n/a + -
Uterus 
-
n/a + n/a + n/a + n/a 
Placenta + n/a + n/a + n/a + n/a 
n/a = not applicable 
* Euthanatized at 10 days post challenge 
** Died 5 days post challenge 
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Figure 3. Bluetongue virus endpoint titers from RBCs obtained from BTV challenged 
pregnant bitches. Reciprocal of the dilution by days post challenge. Bitch 4 died on day 5. 
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Discussion 
Results of this study show that cell culture adapted BTV can cause infection, 
viremia, and abortion in pregnant bitches. The virus used was derived from a commercial 
modified live 4-component canine vaccine contaminated with BTV. Three of the 4 bitches 
were observed to abort and necropsy evidence indicated that the fourth bitch also aborted. 
The challenge administered to the bitches was derived from cell culture adapted BTV. 
Bluetongue virus was recovered from blood prior to and following abortion, and was isolated 
from maternal and fetal tissues. 
Clinical signs for the BTV challenged bitches were not unique or pathognomonic. 
Abortion due to BTV could not be definitively determined by the clinical signs shown by 
these animals. Vomiting and a febrile response initially occurred, followed by depression 
and anorexia. Only in one bitch was there respiratory distress similar to that reported in field 
cases.'*'^ This is in contrast to the histopathology and in situ hybridization findings of 
pulmonary edema and lung involvement in the study by Brown et. al. The tissues examined 
were representative tissues from bitches in this study.® Abortion occurred 4 to 6 days afl:er 
administration of the challenge, slightly longer than some of the observations in the field 
cases. In each of the observed abortions in this study, a rising fever and viremia preceded 
abortion. The death of the one bitch could not be conclusively linked to the BTV infection, 
but occurred within a day of aborting. 
Viremia during days 1 to 9 days post BTV challenge is in contrast to the viral 
persistence lasting for 100 to 160 days and 38 to 100 days noted respectively in cattle and 
sheep for BTV.®''° The clearing of the BTV viremia is more characteristic of African horse 
sickness virus (AHSV) infection, another Orbivirus, in bitches. 
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Historically BTV isolation has required isolation via intravenous inoculation of 
embryonated eggs, with cell culture being considered less sensitive. In these cases, as the 
BTV isolate in this study is of cell culture adapted origin, isolation in cell culture was as 
sensitive as embryonated egg isolation when evaluated in our preliminary studies (data not 
shown). 
The lack of seroconversion for 3 of the 4 bitches as measured by the cELISA may be 
due to the short, 10 day period for this study. The 2 surviving bitches that did not 
seroconvert by the end of the study had a rising inhibition percentage. Whether a different 
threshold would be more appropriate than the 50 percent inhibition threshold established for 
ruminants is of interest. Based on the 1 positive bitch and the assumed continued response if 
the 2 other surviving bitches had been allowed to develop a himioral immune response, the 
cELISA appears to be an appropriate method for determining seroprevelence to BTV in 
bitches. 
This study provides definitive evidence that cell culture adapted BTV administered 
by a route similar to that used for vaccines, causes abortion in pregnant bitches. Bluetongue 
virus was recovered from all 4 of the bitches during clinical illness, 3 of 4 of the bitches were 
observed to abort, and BTV was reisolated from various tissues of the bitches. The origin of 
the cell culture adapted BTV was from a contaminated vaccine that had been associated with 
abortion or abortion and death in pregnant bitches. This study emphasizes the need for 
adequate veterinary biological testing during the manufacturing of vaccines to assure that 
vaccines are free of BTV or any contaminates. 
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CHAPTER 4. SUSCEPTIBmiTY OF NON PREGNANT DOGS AND SHEEP TO 
CELL CULTURE ADAPTED BLUETONGUE VIRUS 
A paper to be submitted to the American Journal of Veterinary Research 
Linn A. Wilbur, DVM, MS;'' Randall L. Levings, DVM, MS;=' Jack C. Rhyan, D.V.M., M.S.;" 
lone R. Stoll;^ James F. Evermann, PhD;"^ Ricardo. F. Rosenbusch, D.V.M., Ph.D.'' 
Abstract 
A cell culture adapted bluetongue virus (BTV), isolated from a contaminated 
commercial modified live 4-component canine vaccine, and the contaminated canine 
vaccine, were administered to various ages of yoimg dogs (6 and 12 week old), to juvenile 
dogs, and to pregnant bitches. No adverse clinical signs or febrile response were observed 
in the non pregnant dogs. In a second experiment, washed red blood cells (RBC) from BTV 
isolate-challenged pregnant bitches that were collected during the time of abortion was given 
to non pregnant sheep and pregnant bitches. The pregnant dogs in both the first and second 
experiment died, aborted and died, or aborted and were euthanatized. Sheep exhibited a 
febrile response and mild clinical signs of 4 days duration and subsequently recovered. 
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Plant Health Inspection Service, USD A, PO Box 844, Ames, L\ 50010 
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Seroconversion occurred in all of the 12 week old dogs and in a portion of the 6 week 
old dogs, but did not occur until at least 14 days post challenge. All the sheep receiving the 
RBC challenge seroconverted. Bluetongue virus was isolated from tissues collected at 
necropsy from non pregnant dogs at 10 days post challenge but not from non pregnant dogs 
at 24 days post challenge. Virus was isolated from multiple tissues from the pregnant bitches 
but not from the bitches' fetuses. 
These studies demonstrate that no acute clinical disease occurred in non pregnant 
dogs, though virus could be isolated and there was a detectable BTV serological response 
following administration of a BTV contaminated modified live vaccine or a BTV isolate 
from the contaminated vaccine. No transfer of BTV could be detected from non pregnant 
dog to dog. Mild clincial disease occurred in sheep from the cell culture adapted BTV 
isolate and the pregnant bitches are a theoretical possible source for infection of BTV 
Culicoides spp. vectors. 
Introduction 
Bluetongue virus occurred as a contaminant in a modified live, multivalent canine 
distemper, canine parvovirus, canine parainfluenza, and canine adenovirus-2 vaccine and 
was distributed for use in the veterinary community and by animal owners.Dogs of all 
ages and pregnancy status received the BTV contaminated vaccine prior to recognition that it 
was contaminated. Abortion and death was reported as occurring in pregnant bitches 
following vaccination.^ Administration of modified live vaccines to pregnant animals is not 
a recommended procedure.'*'^ Multicomponent, modified live vaccines are recommended for 
administration to dogs as young as 6 weeks of age by veterinary manufacturers and may be 
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practiced in even yonnger age dogs when colostrum deprived.® No acute disease was 
reported from non pregnant dogs following field administration of the contaminated vaccine. 
The first part of this study examines the effect of cell culture adapted BTV alone and in 
combination with a modified live viral vaccine on non pregnant dogs. 
Bluetongue virus is primarily transmitted to ruminants via various biting midges of 
the Culicoides spp. that have ingested BTV contaminated blood from viremic ruminants.' 
Historically, BTV was considered to be a disease confined to ruminants.®"'" With the 
demonstration of viremia in pregnant bitches following administration of a BTV isolate 
obtained from a BTV contaminated vaccine, there exists the possibility that these dogs could 
serve as a point source for spread of BTV. The infectivity of cell culture adapted BTV for 
sheep injected with blood from viremic dogs is examined in the second experiment. 
Materials and Methods 
Non pregnant dogs 
Twelve 6 week old, mixed sex, purebred beagles, seronegative to BTV, were 
obtained from a commercial dog colony where dams were routinely vaccinated with 
commercial canine vaccines. Four 6 week old, four 12 week old, and four juvenile, BTV 
seronegative purebred beagles, mixed sex, were obtained from the National Veterinary 
Services Laboratories (NVSL) specific pathogen free (SPF) dog colony. The NVSL dog 
colony is maintained unvaccinated. Non pregnant dogs were housed in climate controlled 
environments on commercial, plastic coated, expanded metal pads in separate groups based 
on age and treatment and allowed to co-mingle within their group. Supplemental zoned heat 
was supplied based on age and animal condition. The floor of each pen was washed twice 
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daily and the dogs were fed a commercial dry dog food supplemented with commercial wet 
food. 
Pregnant dogs 
Eight pregnant bitches were obtained from commercial purebred beagle kennels at 
various times and were all in at least second parturition. Bitches were observed to have been 
mated and all animals were believed to be in mid to late gestation. Bitches had been 
routinely vaccinated with various manufacturers multicomponent vaccines against common 
canine diseases and rabies. All bitches were seronegative to BTV. Pregnant bitches were 
housed in a climate controlled environment in separate pens, in treatment groups of 2 bitches 
per room. The floor of the pen was washed twice daily and the bitches fed a commercial dry 
dog food supplemented with commercial wet food. Bitches had fence line contact within 
each room, but no contact with other dogs. 
Sheep 
Four mixed breed, but predominantly wool breed, sheep were obtained from a 
commercial sheep source. Vaccination history of the sheep was unknown. All sheep were 
seronegative to BTV. Sheep were maintained in climate controlled rooms, 2 sheep per 
room. The pens were washed daily. Animals were fed a commercial pelleted feed and 
alfalfa cubes. 
Experiment 1 challenge 
Bluetongue virus was isolated as previously described from a modified live, 
multivalent canine distemper, canine parvovirus, canine parainfluenza, and canine 
adenovirus-2 vaccine that had been associated with abortion and death in pregnant bitches.' 
One additional passage in a baby hamster kidney cell line was used to expand the isolate 
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from the previous two passages in a Vero cell line (African green monkey kidney cell line). 
The contaminated BTV vaccine isolate was end point titrated by cytopathic effect (CPE) in 
Vero cells prior to being diluted for challenge. The titer was calculated by the method of 
Spearman and Karber as modified by Finney.^' The isolate was diluted 1:16.3 in MEM 
without fetal bovine serum and designated as the BTV isolate challenge. The challenge, as 
used, was examined for other contaminating viruses by the methods described in Section 9 of 
the Code of Federal Regulations.'^ 
Sufficient vials originating from the same lot of the contaminated viral vaccine were 
rehydrated with sterile water on each day of challenge, pooled, and designated as the BTV 
contaminated vaccine challenge. The BTV virus content of representative vials of the BTV 
contaminated vaccine were previously titered in Vero cells as described above, except the 
canine vaccine was chloroform treated to inactivate the canine distemper and canine 
parainfluenza virus and neutralized with antiserum specific to canine adenovirus 2 prior to 
titering. Vero cells were not permissive for viral replication of canine parvovirus. 
Multiple vials of one serial of commercial vaccine from the same manufacturer, 
containing the same modified live viruses, but known to be free of BTV contamination, was 
rehydrated with sterile water on the day of challenge, pooled, and designated as the non 
contaminated vaccine challenge. 
The twelve 6 six week old dogs from the commercial colony were housed in 2 rooms, 
6 dogs per room. Four of the first group of 6 (3 males, 1 female) received 1.0 ml of the 
BTV isolate challenge by the intramuscular route in one site on the hind leg with a 22-gauge 
1 inch needle and syringe. Four of the second group of 6 dogs (3 males, 1 female) received 
1.0 ml of the BTV contaminated vaccine challenge by the same route. The remaining 2 
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dogs in each group (2 male, 1 male and 1 female, respectively) were not inoculated and 
served as contact controls. Dogs were observed, rectal temperatured, and clinical signs 
recorded daily from the day prior to challenge to 24 days post challenge. Blood was 
collected for serum on days 0 and every 3 to 4 days post challenge. On day 10 post 
challenge, half of the dogs in each challenge group and contact control group were humanely 
euthanatized, necropsied, and samples collected for viral isolation. On day 14 post 
challenge, the remaining dogs that were previously challenged were administered 1.0 ml of 
the same challenge by the same route. On day 21 all remaining dogs were humanely 
euthanatized, necropsied, and samples collected for viral isolation. 
The four 6 week old dogs (4 males) from the NVSL SPF colony were housed as a 
group as were the four 12 week old NVSL SPF dogs (4 females). Two dogs in each group 
received 1.0 ml of the BTV isolate challenge and the other two, 1.0 ml of the BTV 
contaminated vaccine challenge by the same intramuscular route. Dogs were rechallenged 
14 days after the first challenge. Dogs were observed and blood sampled at 3 to 4 day 
intervals as previously described for 21 days and 35 days respectively. The dogs were 
humanely euthanatized, necropsied, and samples collected for viral isolation at the 
conclusion of the observation period. 
The four juvenile dogs (3 female, 1 male) were housed as a group. Two dogs 
received 1.0 ml of the BTV isolate challenge and the other 2, 1.0 of the BTV contaminated 
vaccine challenge as previously described. Dogs were observed and blood sampled as the 
other groups, but the dogs were euthanatized, necropsied, and samples collected on day 14 
post challenge without receiving a second challenge. 
Six of the pregnant bitches were divided into 3 groups, 2 dogs per room. One group 
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received 1.0 ml of the BTV isolate challenge, the second group 1.0 ml of the BTV 
contaminated vaccine challenge, and the third group 1.0 ml of the non contaminated vaccine. 
All challenges were administered in one site in the rear leg. Bitches were observed twice 
daily starting one day prior to challenge and blood samples for serum collected on the day of 
challenge and at 3 to 4 day intervals. Bitches were observed more frequently, up to hourly 
intervals, as they developed clinical signs. All abortions and live births were recorded and 
fetal and placental tissues collected. 
Experiment 2 challenge 
Blood was collected from bitches who had received the BTV isolate from the 
contaminated vaccine in a previous experiment. The challenge used was from a pool of 
blood from dogs demonstrated to be viral positive (viremic) and from days that coincided 
with the time of observed abortions. The EDTA treated blood sample was centrifliged at 
750 X g for 10 minutes and the serum removed. The RBC were washed by suspending the 
RBC pellet in sterile PBS at 4 C, equal to the removed serum volume and then centrifiiging 
at 750 X g for 15 minutes at 4 C. The procedure was repeated for a total of 3 washes. The 
final washed RBC pellets were suspended with an equal volume of buffered lactose peptone 
with 375 ^g/ml gentamycin, 50 (ig/ml kanamycin, and 50 ^ig/ml amphotercin B and stored at 
4 C until used. The RBC BTV challenge was administered undiluted. 
The BTV blood challenge was titrated in 10 day old chicken egg embryos and the 
embryos observed for 7 days. The buffered lactose peptone-stored RBC's were centrifriged 
and 0.2 ml of packed cells lysed in 4 ml of sterile distilled water and then QS to 10 ml in 
buffered lactose peptone with antibiotics for a final dilution of 1 to 20. Additional 1 to 5 
dilutions were made in buffered lactose peptone with antibiotics. The chorioallantoic vessels 
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of the embryos were visualized by candling, a portion of the egg shell removed, and 0.1 ml 
intravenously administered." Embryos dying from day 2 through 7 were used to determine 
the titer by the methods of Spearman and Karber as modified by Finney." 
Two pregnant bitches and 4 sheep (2 female, 2 male) received a total of 2.0 ml, 
divided equally in each hind leg, of the RBC BTV challenge administered with a 23 g 1 inch 
needle and syringe. Bitches were observed and rectal temperature recorded at least twice 
daily starting on the day prior to challenge through day 10 or as long as the bitches survived. 
As bitches developed clinical signs they were observed more frequently, up to hourly 
intervals. Blood samples for serum were collected on the day of challenge and at 3 to 4 day 
intervals. All abortions and live births from the bitches were recorded and fetal and placental 
tissues collected as appropriate. Sheep were observed and rectal temperature recorded daily, 
and twice daily as clinical signs occurred, from the day prior to challenge to day 20 post 
challenge. Blood samples for serum were collected on the day of challenge and at 3 to 4 day 
intervals. All surviving sheep were necropsied on day 20 and tissue samples collected for 
viral isolation. 
Animal care and approval 
The experiments were conducted with the approval of the NVSL Animal Care and 
Use Committee and in accordance with the NIH guidelines and the Animal Welfare Act. 
Animals were acclimated prior to initiation of all studies. 
Blood samples 
Serum was separated from clotted blood by centrifiigation at 1,800 X g- for 10 
minutes and stored at 4 C. A commercial BTV competitive ELISA (cELISA) diagnostic kit 
' Protocol courtesy of the Diagnostic Virology Laboratory, National Veterinary Services Laboratory, Ames, L\. 
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was used to determine BTV antibody levels/ 
Viral isolation from tissues 
Tissues were treated as previously described' substituting MEM media containing 
75 units/ml penicillin, 225 units/ml streptomycin, and 150 jig/ml gentamycin. Brain, spinal 
cord, heart, muscle, kidney, limg, spleen, liver, bone marrow, mesenteric lymph node, aorta, 
colon, tonsil, and small intestine were examined when possible. Uterus, uterine fluid, and 
placenta tissues were individually examined from each bitch where possible. Four hundred 
microliters (400 ^il) of supernatant was inoculated onto 25 cm^ flasks of confluent Vero cell 
culture and 400 ^.1 onto a 25 cm^ flask of embryonic bovine kidney primary cells for each 
supernatant. Flasks were incubated at 36 C in a 5% CO, incubator. Flasks were observed 
daily for CPE and frozen at -70 C when CPE was observed. Flasks not exhibiting CPE were 
subpassaged 2 additional times at 4 to 6 day intervals and if no CPE observed were 
considered negative. Flasks with CPE were thawed at room temperature, centrifiiged at 200 
Xg for 10 minutes, and the supernatant individually collected. Vero cell cultures in 8 
chamber glass slides, 24 hours after seeding and incubating at 36 C in a 5% CO2 incubator, 
were inoculated with 0.1 ml per chamber of the supernatant and fiuther incubated at 36 C in 
a 5% CO2 incubator. Slides were examined daily and fixed with acetone if CPE was evident 
or fixed at 7 days if no CPE was observed. Cells were examined using a direct fluorescent 
antibody BTV conjugate® and an ultraviolet light microscope and considered a positive 
isolate if specific BTV fluorescence was observed. 
^ Bluetongue antibody test kit, cELISA, Veterinary Diagnostic Technology, Inc., Wheat Ridge, CO 80033 
® Bluetongue fluorescent antibody conjugate. National Veterinary Services Laboratories, Ames, lA 
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Results 
Experiment 1 
Challenge 
The viral titer of the BTV isolate titered 6.8 log[o tissue culture infective doses fifty 
percent end point (10^'® TCID50) per ml, which after dilution resulted in a challenge of 10^ ® 
TCID50 per ml. The BTV viral titer of a representative sample of the contaminated vaccine 
titered 10^"^ TCID50 per ml. No viral contaminants were foimd in the BTV isolate challenge. 
Observations 
Non pregnant dogs. No significant clinical signs attributable to BTV were observed 
in any of the 6 week old, 12 week old, or juvenile non pregnant dogs following either the 
initial challenge or the second challenge. Intermittent loose stools in the majority of the 6 
week old dogs occurred following the second challenge of the BT^'^ isolate and the BTV 
contaminated vaccine, but also was observed in the contact controls and was attributed to the 
diet. Rectal temperatures in all of the non pregnant dogs for the observation period were 
within the normal range (37.8 C to 39.1 C),'^ except for 3 dogs in the juvenile group that had 
temperatures exceeding normal, on days 3, 3, and 5 to 7 post initial challenge, respectively, 
with a maximum temperature of 39.6 C. These represented a BTV isolate dog and 2 BTV 
contaminated vaccine dogs. 
Pregnant bitches. The 2 bitches receiving the BTV isolate remained normal through 
day 4 post challenge. Starting on day 5 post challenge both bitches had elevated 
temperatures, yellowish feces, dark mucoid vaginal discharge, and appeared generally 
restless. The bitches receiving the BTV isolate aborted on day 5 and 6 respectively. The 
bitch aborting on day 5 aborted 5 fetuses, the one aborting on day 6, 1 fetus. Both bitches 
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continued to show clinical signs after abortion including vaginal discharge, listlessness, 
rattled breathing, and coughing. The second aborting bitch died on day 8 post challenge. 
The first aborting bitch was euthanatized on day 8 post challenge due to a general decline in 
health and difficult breathing. Both bitches exhibited an elevated temperature at the time of 
abortion followed by a gradual temperature decline. The bitch that was euthanatized had a 
subnormal temperature at the time of euthanasia. 
The 2 bitches receiving the BTV contaminated vaccine remained normal through day 
2 post challenge. On day 3 one bitch exhibited yellowish mucoid stool and both animals had 
distended abdomens. One bitch on day 4 had a rapidly declining temperature and mucoid 
diarrhea and died. No abortion was noted. The second bitch on day 4 exhibited a febrile 
response followed by a rapidly declining temperature, which by day 5 was subnormal. On 
day 5 that bitch was observed to vomit, had a greenish vaginal discharge, and aborted 2 
fetuses. The bitch died on day 5. At necropsy the first bitch had 8 retained fetuses and the 
second bitch 5 fetuses. 
The 2 bitches receiving the non contaminated vaccine remained normal. The first 
bitch whelped 7 live puppies 10 days post challenge and the second bitch 7 live puppies 14 
days post challenge. 
Serum samples 
The earliest response in the dogs from dams who had been routinely vaccinated was 
on day 10 post challenge when 1 of the dogs receiving the BTV isolate had a 52 percent 
inhibition cELISA reaction, indicative of a positive serological titer. Subsequently one of the 
BTV contaminated vaccine group and another of the dogs receiving the BTV isolate had a 
positive cELISA reaction, both on day 17. The contact controls remained negative through 
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the study (Figure 1 to 3). Both of the dogs from non vaccinated dams receiving the BTV 
isolate were positive on day 20, while the dogs from non vaccinated dams receiving the BTV 
contaminated vaccine remained seronegative through the study (Figures 4 and 5). 
Combining the results from routinely vaccinated and non vaccinated dams showed a slightly 
greater average response for dogs receiving the BTV isolate than the BTV contaminated 
vaccine. Only on day 17 and 20 could the average percent inhibition be considered positive 
for the BTV isolate group. For all other days, dogs from all groups were negative 
(Figure 6). The number of positive dogs by days post challenge for the groups of 6 week old 
dogs is summarized in Table 1. 
One of the dogs that received the BTV isolate in the group of 12 week old dogs 
Became cELISA positive on day 14 post challenge and the remaining dog in that group and 
the BTV vaccine dogs were positive by day 21 (Figures 7 and 8). A summary of the 
seroconversions among 12 week old dogs is depicted in Figure 9 and Table 2. 
Table 1. Sero conversion of 6 week old dogs for the 5 treatment groups. A positive was any 
dog whose serum tested ^50% inhibition for any bleeding date within the specified time. 
Treatment group 0 to 10 DPC 14 to 24 DPC 0 to 24 DPC 
BTV isolate, vaccinated dam 1/4 1/2 2/4 
BTV contaminated vaccine, 
vaccinated dam 0/4 1/2 1/4 
BTV isolate, non vaccinated dam 0/2 2/2 2/2 
BTV contaminated vaccine, non 
vaccinated dam 0/2 0/2 0/2 
Contact controls, vaccinated dam 0/4 0/2 0/4 
DPC = day post challenge 
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Figure 1. Serological response of 6 week old dogs from routinely vaccinated dams 
following administration of 10^ ® TCID50 of a BTV isolate recovered from a canine modified 
live vaccine. Greater than 50% inhibition is considered a positive antibody titer in 
ruminants. No threshold inhibition level has been determined for dogs. N = 4 for day 0 to 
10 post challenge and n = 2 for days 14 to 24 post challenge. 
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Figure 2. Serological response of 6 week old dogs from routinely vaccinated dams 
following administration of a contaminated vaccine containing 10 TCED50 of BTV. 
Greater than 50% inhibition is considered a positive antibody titer in ruminants. No 
threshold inhibition level has been determined for dogs. N = 4 for day 0 to 10 post 
challenge and n = 2 for days 14 to 24 post challenge. 
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Figure 3. Serological response of 6 week old dogs from routinely vaccinated dams that were 
not challenged and served as contact controls in the routinely vaccinated dams BTV isolate 
and BTV contaminated vaccine groups. Greater than 50% inhibition is considered a positive 
antibody titer in ruminants. No threshold inhibition level has been determined for dogs. 
N = 4 for day 0 to 10 post challenge and n = 2 for days 14 to 24 post challenge. 
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Figure 4. Serological response of 6 week old dogs (n = 2) from SPF, non vaccinated dams 
following administration of a 10^ ® TCID50 of a BTV isolate recovered from a canine 
modified live vaccine. Greater than 50% inhibition is considered a positive antibody titer in 
ruminants. No threshold inhibition level has been determined for dogs. 
72 
110% 1 
90% -
70% -
c o 
S 50% -
-C 
g 30% -
Q. 
10% -
-10% 
-30% 
-1 4 9 14 19 24 
Days post challenge 
Figure 5. Serological response of 6 week old dogs (n = 2) from SPF, non vaccinated dams 
following administration of a contaminated vaccine containing 10^"^ TCID50 of BTV. 
Greater than 50% inhibition is considered a positive antibody titer in ruminants. No 
threshold inhibition level has been determined for dogs. 
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24 
Figure 6. Serological response by treatment for all 6 week old dogs. The BTV isolate group 
received 10®"® TCLDm of a BTV isolate recovered from a canine modified live vaccine. The 
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BTV contaminated vaccine group received a commercial vaccine containing 10^"^ TCID50 
BTV. The contact controls received not treatment. Greater than 50% inhibition is 
considered a positive antibody titer in ruminants. No threshold inhibition level has been 
determined for dogs. N = 6 for days 0 to 10 post challenge and n = 4 for days 14 to 25 for 
both the BTV isolate and BTV contaminated vaccine groups; n = 4 for days 0 to 10 post 
challenge and n = 2 for days 14 to 25 for the contact controls.. 
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Figiire 7. Serological response of 12 week old dogs ( n = 2) from SPF, non vaccinated dams 
following administration of 10^ ® TCID50 of a BTV isolate recovered from a canine modified 
live vaccine. Greater than 50% inhibition is considered a positive antibody titer in 
ruminants. No threshold inhibition level has been determined for dogs. 
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Figure 8. Serological response of 12 week old dogs (n = 2) from SPF, non vaccinated dams 
following administration of a contaminated vaccine containing 10^^ TCID50 of BTV. Greater 
than 50% inhibition is considered a positive antibody titer in ruminants. No threshold 
inhibition level has been determined for dogs. 
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Figure 9. Serological response by treatment for the 12 week old dogs. The BTV isolate 
group (n = 2) received 10^"® TCIDjq of a BTV isolate recovered from a canine modified live 
vaccine. The BTV contaminated vaccine group (n = 2) received a commercial vaccine 
containing 10^-^ TCID50 of BTV. Greater than 50% inhibition is considered a positive 
antibody titer in ruminants. No threshold inhibition level has been determined for dogs. 
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Table 2. Numbers of 12 week old dogs from non vaccinated dams considered serologically 
positive over total number of dogs for the 2 treatment groups. A positive was any dog whose 
serum tested ^50% inhibition for any bleeding date within the specified time. 
Treatment group 0 to 10 DPC 14 to 25 DPC 25 to 35 DPC 
BTV isolate 0/2 2/2 2/2 
BTV contaminated vaccine 0/2 2/2 2/2 
DPC = day post challenge 
Both treatment groups of the juvenile dogs remained serologically negative through 
day 10 post challenge when they were humanely euthanatized and necropsied (Figures 10 to 
12). 
The serological results for the pregnant bitches from the BTV isolate, the BTV 
contaminate and the non contaminated vaccine are provided in Figure 13. Only 1 bitch from 
the BTV isolate group seroconverted. Of the two groups receiving BTV (BTV isolate and 
BTV contaminated vaccine challenges), none of the animals survived beyond day 8. Neither 
of the bitches in the non contaminated group seroconverted through day 14 when they were 
humanely euthanatized and tissues collected. 
Viral isolation from tissues 
Viral isolation from the 6 week old dogs occurred only in the dogs challenged with 
the BTV isolate and the dogs challenged with the BTV contaminated vaccine that were 
euthanatized and necropsied 10 day post challenge (Tables 3 and 4). No viral isolation 
occurred in the contact control dogs at either 10 or 24 days post challenge or in the BTV 
isolate or BTV contaminated vaccine groups at 24 days post challenge. The most consistent 
tissue for isolation from the 10 days post challenge groups was the spleen, followed by the 
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Figure 10. Serological response of juvenile dogs (n = 2) from SPF, non vaccinated dams 
following administration of a 10^"® TCID50 of a BTV isolate recovered from a canine 
modified live vaccine. Greater than 50% inhibition is considered a positive antibody titer in 
ruminants. No threshold inhibition level has been determined for dogs. 
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Figure 11. Serological response of juvenile dogs (n = 2) from SPF, non vaccinated dams 
following administration of a contaminated vaccine containing 10^'^ TCIDjo of BTV. 
Greater than 50% inhibition is considered a positive antibody titer in ruminants. No 
threshold inhibition level has been determined for dogs. 
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Figure 12. Serological response by treatment for the juvenile dogs. The BTV isolate group 
(n = 2) received 10^'® TCIDjo of a BTV isolate recovered from a canine modified live 
vaccine. The BTV contaminated vaccine group(n = 2) received a commercial vaccine 
containing 10^"^ TCID50 of BTV. Greater than 50% inhibition is considered a positive 
antibody titer in ruminants. No threshold inhibition level has been determined for dogs. 
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Figure 13. Serological response by treatment for the pregnant bitches. The BTV isolate 
group received 10^ ® TCIDso of a BTV isolate recovered from a canine modified live vaccine. 
The BTV contaminated vaccine (BTV cont. vacc.) group received a commercial vaccine 
containing 10^"^ TCID50 of BTV. The non contaminated vaccine (Non cont. vacc.) Group 
received a serial of vaccine from the same manufacturer but know to be not contaminated 
with BTV. Greater than 50% inhibition is considered a positive antibody titer in ruminants. 
No threshold inhibition level has been determined for dogs. 
Table 3. Viral isolation on Vero and embryonic bovine kidney cells from 6 week old dogs from routinely vaccinated dams. A 
tissue was considered positive if BTV was isolated from either cell. Results are entered as the number positive versus number 
tested. 
6 week old dogs from routinely vaccinated dams 
BTV isolate BTV contaminated vaccine BTV contact control 
lODPC 24 DPC 
Isolation 
totals 10 DPC 24 DPC 
Isolation 
totals 10 DPC 24 DPC 
Isolation 
totals 
Brain 0/2 0/2 0/4 0/2 0/2 0/4 0/2 0/2 0/4 
Spinal cord ns ns ns ns ns ns ns ns ns 
Heart 0/2 0/2 0/4 0/2 0/2 0/4 0/2 0/2 0/4 
Liver 1/2 0/2 1/4 0/2 0/2 0/4 0/2 0/2 0/4 
Lung 1/2 0/2 1/4 1/2 0/2 1/4 0/2 0/2 0/4 
Kidney 2/2 0/2 2/4 1/2 0/2 1/4 0/2 0/2 0/4 
Muscle 0/2 0/2 0/4 1/2 0/2 1/4 0/2 0/2 0/4 
Spleen 2/2 0/2 2/4 2/2 0/2 2/4 0/2 0/2 0/4 
Bone marrow 0/2 0/2 0/4 0/2 0/2 0/4 0/2 0/1 0/3 
Mesenteric LN 1/2 0/2 1/4 2/2 0/2 2/4 0/2 0/2 0/4 
Aorta 0/2 0/2 0/4 1/2 0/2 1/4 0/2 0/2 0/4 
Uterus 0/1 0/1 0/2 0/1 0/1 0/2 ns O/I 0/1 
Small intestine 1/2 0/2 1/4 1/2 0/2 1/4 0/2 0/2 0/4 
Colon 0/2 0/2 0/4 1/2 0/2 1/4 0/2 0/2 0/4 
Tonsil 1/2 0/2 1/4 2/2 0/2 2/4 0/2 0/2 m 
DPC = days post challenge, ns = no sample, LN = lymph node 
83 
Table 4. Viral isolation on Vero and embryonic bovine kidney cells from 6 week old dogs 
from SPF, non vaccinated dams. A tissue was considered positive if BTV was isolated from 
either cell. Results are entered as the number positive versus number tested. 
6 week old dogs from SPF, non 
vaccinated dams 
BTV isolate 24 
DPC 
BTV 
contaminated 
vaccine 24 
DPC 
Brain 0/2 0/2 
Spinal cord ns ns 
Heart 0/2 0/2 
Liver 0/2 0/2 
Lung 0/2 0/2 
Kidney 0/2 0/2 
Muscle 0/2 0/2 
Spleen 0/2 0/2 
Bone marrow 0/2 0/2 
Mesenteric LN 0/2 0/2 
Aorta 0/2 0/2 
Uterus ns ns 
Small intestine 0/2 0/2 
Colon 0/2 0/2 
Tonsil 0/2 0/2 
DPC = days post challenge, ns = no sample, LN = lymph node 
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mesenteric lymph node, kidney, tonsil, and liver. No isolation occurred from the brain, 
heart, bone marrow, or uterus. 
No viral isolations occurred in the 12 week old dogs when tissues were collected at 
35 days post challenge (Table 5). 
Only tissues from 1 animal in each treatment group of the juvenile dogs were tested. 
The lung in the BTV isolate group was the only tissue positive when samples were collected 
at 10 days post challenge (Table 6). 
Isolation results for the pregnant bitches is reported in Table 7. Tissues and placenta 
from the BTV isolate and the BTV contaminated vaccine group were found consistently 
positive for BTV. Tissues from the aborted or retained fetuses yielded sporadic virus 
isolation. No BTV was isolated from the bitches receiving the non contaminated vaccine. 
Experiment 2 
Challenge 
The RBC challenge titered 10^ ' egg lethal dose 50% (ELD50) for a challenge of 10^"'* 
ELD50 in the 2 ml challenge dose. 
Observations 
Sheep. Sheep receiving the RBC challenge exhibited no clinical signs through day 6 
post challenge. On day 6 rapid respiration, lethargy, and inappetance were observed which 
lasted through day 10. Rectal temperatures peaked on day 7 for 4 of 4 sheep and again on 
day 10 for 2 of 4 sheep (Figure 14). Baseline temperatures for the sheep were consistently in 
the high normal to slightly above normal range for all days, but temperatures exceeded those 
baselines for the days noted. Baseline temperatures observed were consistent with previous 
observations for sheep held in climate controlled facilities when sheep had any appreciable 
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Table 5. Viral isolation on Vero and embryonic bovine kidney cells from 12 week old dogs 
from SPF, non vaccinated dams. A tissue was considered positive if BTV was isolated from 
either cell. Results are entered as the number positive versus number tested. 
12 week old dogs from SPF, non 
vaccinated dams 
BTV 
BTV isolate 35 contaminated 
DPC vaccine 35 DPC 
Brain 0/2 0/2 
Spinal cord ns ns 
Heart 0/2 0/2 
Liver 0/2 0/2 
Lung 0/2 0/2 
Kidney 0/2 0/2 
Muscle 0/2 0/2 
Spleen 0/2 0/2 
Bone marrow 0/2 0/2 
Mesenteric LN 0/2 0/2 
Aorta 0/2 0/2 
Uterus ns ns 
Small intestine 0/2 0/2 
Colon 0/2 0/2 
Tonsil 0/2 0/2 
DPC = days post challenge, ns = no sample, LN = lymph node 
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Table 6. Viral isolation on Vero and embryonic bovine kidney cells from juvenile dogs from 
SPF, non vaccinated dams. A tissue was considered positive if BTV was isolated from 
either cell. Results are entered as the number positive versus nimiber tested. 
Juvenile dogs from SPF, non vaccinated 
dams 
BTV isolate 
10 DPC 
BTV 
contaminated 
vaccine 
10 DPC 
Brain 0/1 0/1 
Spinal cord ns ns 
Heart 0/1 0/1 
Liver 0/1 0/1 
Lung 1/1 0/1 
Kidney 0/1 0/1 
Muscle 0/1 0/1 
Spleen 0/1 0/1 
Bone marrow 0/1 0/1 
Mesenteric LN 0/1 0/1 
Aorta 0/1 0/1 
Uterus 0/1 0/1 
Small intestine 0/1 0/1 
Colon 0/1 0/1 
Tonsil 0/1 0/1 
DPC = days post challenge, ns = no sample, LN = lymph node 
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Table 7. Viral isolation on Vero and embryonic bovine kidney cells from pregnant bitches 
and fetuses. A tissue was considered positive if BTV was isolated from either cell. Results 
are entered as the number positive versus number tested. 
Challenge group 
BTV contaminated Non contaminated 
BTV isolate vaccine vaccine 
Bitches Fetuses Bitches Fetuses Bitches Fetus 
Brain 1/2 1/6 2/2 13/15 0/2 ns 
Spinal cord 2/2 2/2 0/2 
Heart 1/2 0/2 0/2 
Heart/aorta 1/6 0/15 ns 
Liver 2/2 0/6 2/2 4/15 0/2 ns 
Lung 2/2 0/6 2/2 1/15 0/2 ns 
Kidney 2/2 0/6 2/2 4/15 0/2 ns 
Muscle 2/2 2/2 0/2 
Spleen 2/2 0/6 2/2 2/15 0/2 ns 
Bone marrow 2/2 2/2 0/2 
Mesenteric LN 2/2 2/2 0/2 
Aorta 2/2 2/2 0/2 
Uterus 2/2 2/1 0/2 
Small intestine 2/2 2/2 0/2 
Colon 2/2 2/2 0/2 
Intestine 0/6 1/15 ns 
Tonsil 2/2 2/2 0/2 
Placenta 6/6 14/15 ns 
Uterine/ 
Placental fluid 2/2 8/12 
ns = no sample, LN = lymph node 
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Figure 14. Rectal temperature of sheep challenged with dog RBC from bitches aborting 
after challenge with a BTV isolate from a contaminated canine vaccine. 
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amount of wool. Sheep returned to baseline temperatures following day 10 and no additional 
signs were noted. 
Pregnant bitches. The pregnant bitches remained normal through day 4. Vomiting, 
inappetance, increased activity, and a general "ill at ease" behavior were noted on day 5. 
Vomiting, depression, and rapidly falling temperatures were observed on day 6. The first 
bitch died on day 6. The second bitch continued to be depressed and the bitches temperature 
declined further. The second bitch aborted 8 pups and was euthanatized on day 7 upon 
becoming lisdess along with a temperature below 35 C. At necropsy the first bitch had 7 
retained fetuses and the second bitch 2 retained fetuses. 
Serum samples 
Three of 4 sheep had greater than 50% inhibition by day 10 and all had greater than 
50% inhibition by day 17 (Figure 15). Neither of the pregnant bitches had significant 
percent inhibition by the time of their death or when they were euthanatized (Figure 16). 
Viral isolation from tissues 
Virus was isolated firom all 4 of the sheep firom tissues collected at necropsy at day 
20. No one tissue was found positive in all sheep. The spleen was positive in 3 of 4 sheep 
(Table 8). The majority of the tissues firom the pregnant bitches were foimd positive but the 
aborted fetuses or retained fetuses were only sporadically positive. 
Discussion 
This study found no acute disease or clinical signs elicited by either an initial or a 
second challenge of cell culture adapted BTV in non pregnant female dogs or male dogs, 
regardless if firom routinely vaccinated or unvaccinated dams. No difference was noted by 
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Figure 15. Serological response of sheep (n = 4) following administration of dog RBC from 
aborting bitches that had received a BTV isolate from a contaminated vaccine. Greater than 
50% inhibition is considered a positive antibody titer in ruminants. 
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Figixre 16. Serological response of pregnant bitches following administration of dog RBC 
from aborting bitches that had received a BTV isolate from a contaminated vaccine. Greater 
than 50% inhibition is considered a positive antibody titer in ruminants. No threshold 
inhibition level has been determined for dogs 
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Table 8. Viral isolation on Vero and embryonic bovine kidney cells from non pregnant 
sheep, pregnant bitches, and their fetuses, after receiving dog RBC from aborting bitches 
who had received a BTV isolate from a contaminated vaccine. A tissue was considered 
positive if BTV was isolated from either cell. Results are entered as the number positive 
versus number tested. 
Sheep 21 Bitches Fetuses' 
DPC 
Brain 1/4 2/2 6/8 
Spinal cord 0/4 1/1 
Heart 0/4 1/2 
Heart/aorta 1/8 
Liver 0/4 2/2 2/8 
Lung 0/4 2/2 1/8 
BCidney 0/4 2/2 1/8 
Muscle 0/4 2/2 
Spleen 3/4 2/2 1/8 
Bone marrow 0/4 2/2 
Mesenteric LN 0/4 1/1 
Aorta 1/4 1/1 
Uterus 0/2 2/2 
Small intestine 0/4 2/2 
Colon 0/4 2/2 
Intestine 2/8 
Tonsil 1/4 1/1 
Placenta 15/15 
Uterine/ 14/17 
DPC = days post challenge, LN = lymph node 
' Represents 7 fetus from 1 bitch and a pool of multiple fetus from a 2"'' bitch 
for all tissues except the placenta and uterine fluids. Tissues were tested as a 
pool due to the size of the fetuses. 
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age of animals, whether administered to young dogs or juvenile dogs. No acute adverse 
effects were noted for either the cell culture adapted BTV isolate obtained from a 
contaminated canine modified live vaccine or from the contaminated canine vaccine itself. 
As expected, no spread of the BTV was observed in contact controls. Conversely, those 
same challenges when administered to pregnant bitches produced death or abortion and death 
in both bitches in each group. This is in contrast to another control group who received a 
non contaminated vaccine similar to the contaminated vaccine and from the same 
manufacture. Both bitches in that group whelped normal pups. There was evidence that the 
BTV contaminated vaccine-challenged pregnant bitches had shorter duration to clinical signs 
and died more acutely than did the BTV isolate challenged dogs. Both challenges contained 
equivalent amounts of BTV. 
Most of the dogs which received either the BTV isolate challenge or the BTV 
contaminated vaccine became seropositive. Contact controls remained seronegative. 
Seroconversion typically did not reliably occur in dogs until 14 to 17 days after initial 
vaccination. The younger 6 week old dogs, characteristic of the earliest age for first 
vaccination, had lower and more inconsistent serological responses than older dogs. 
Although 6 week old dogs are considered immimocompetent there is evidence that puppies 
who have nursed and have maternal antibodies are less responsive to vaccination, even when 
no antibodies to the vaccine antigen are passively transferred, than older dogs after the 
passive antibody has waned. This is believed to be due to a central suppression elicited by 
self regulation of immunoglobulin concentrations or may be due to nonimmimoglobulin 
immimosuppressive factors in colostrum and may account for the lack of response of this 
group.® 
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There was no difference between the immune response of the BTV contaminated 
vaccine groups and the BTV isolate groups. No effect on serological response due to 
potential immunosuppressive vaccine component administration was evident. 
Based on these findings, it would be expected that a percentage of dogs in the U.S. 
population would be seropositive for BTV if they had received a vaccination with a BTV 
contaminated vaccine. Any retrospective study to determine if natural infection in dogs with 
BTV occurs would have to be done with serum samples collected prior to the occurrence of 
this contamination event. 
Bluetongue virus could be isolated fi:om non pregnant dogs 10 days after challenge 
with either the BTV isolate or the BTV contaminated vaccine. No differences in isolation 
rate between the two groups were evident. Virus was more consistently isolated in the 
younger dogs than in older dogs. No virus could be isolated in dogs at 24 days post 
challenge or later. Tissues of choice for viral isolation were consistent with 
recommendations for tissue isolation in ruminants, with spleen being the best tissue for 
isolation. 
Previously it had been shown that there was a viremic phase in pregnant bitches that 
coincided with the time of abortion. Blood firom pregnant bitches that had aborted after 
receiving a cell culture adapted BTV was demonstrated to be infective for sheep and capable 
of inducing abortion in other pregnant bitches. Although a potential source for infecting the 
Culicoides spp. vector, the short viremic phase demonstrated in previous experiments and the 
infectivity shown here makes this an imlikely but theoretical possibility. 
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CHAPTERS. GENERAL CONCLUSIONS 
The reporting of disease and death of dogs following administration of a canine 
vaccine, historically safe and effective, lead to the discovery of a viral contaminate and the 
recall of vaccine. Because there was disease caused by an agent in a species not previously 
reported, studies were conducted to determine if the contaminating virus truly was the cause 
of disease. As disease was reported for a very specific portion of a species, based on 
pregnancy status, the question raised was if there was any effect on the rest of that population 
who received the contaminated vaccine. Finally, because of the known method of spread of 
this disease in the normal host by an insect vector, was it possible that a new disease 
reservoir could contribute to spread of the disease to other historically recognized susceptible 
species. 
Bluetongue virus was isolated from a canine modified live vaccine that had been 
previously safe and effective. The association of disease with BTV in dogs was an 
unexpected occurrence as previously BTV was considered only a disease of ruminants. 
Regulatory requirements associated with production and testing of veterinary vaccines had 
theoretically been designed to preclude accidental contamination of vaccines and normally it 
was expected that wild type BTV had, at best, a very low chance of replicating in cell 
culture. To determine if this cell culture adapted BTV could be the cause of disease in dogs, 
both pregnant bitches and non pregnant dogs of various ages were challenged with an isolate 
of the BTV contaminated vaccine or with the BTV contaminated vaccine. Pregnant bitches 
died, aborted, or aborted and died from both of the cell culture adapted BTV sources. A 
shorter period of viremia for the BTV challenged pregnant bitches than for ruminants was 
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demonstrated. Pregnant dogs receiving a non contaminated vaccine remained well and 
whelped live pups. None of the non pregnant dogs showed any clmical signs nor was there 
any evidence that there was transmission from challenged dogs to contact controls. Younger 
dogs had a low rate of seroconversion, while older dogs uniformly seroconverted when held 
for a period normally adequate to elicit an immune response. Virus could be recovered in the 
non pregnant dogs at 10 days post challenge but not at 24 days post challenge. 
Sheep receiving washed red blood cells from aborting bitches showed clinical signs 
and seroconverted. Pregnant bitches aborted and died when receiving the same challenge. 
The isolation of BTV from pregnant bitches and non pregnant dogs raises the 
possibility that dogs could have been a source for transmission of the BTV to other animals 
if bitten by appropriate Culicoides spp. 
Additional experimental or retrospective studies are needed to answer several 
questions. Although these studies demonstrated that seroconversion in non pregnant dogs is 
possible, adequate studies to determine if the general dog population reflected this 
occurrence have not been conducted. Sufficient doses of the vaccine were administered that 
this should be detectable, based on these findings. To further clarify the issue of possible 
transmission via Culicoides spp and the relationship to virus levels in dogs following 
challenge, additional studies using pregnant bitches, midges, and susceptible ruminants 
should be conducted 
The studies reported here confirm that cell culture BTV can cause disease in pregnant 
bitches, can replicate and elicit an antibody response in non pregnant dogs, and was still 
infective in at least one of the natural ruminant hosts. No evidence presently exists for the 
natural transmission of BTV to dogs, but BTV can not now be excluded from disease 
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consideration from iatrogenic soxirces. Additional studies are needed to determine if there is 
any evidence that natural BTV infection occurs in dogs. At the minimum, the studies 
conducted serve to confirm the need for continued and enhanced testing of all biologicals to 
prevent contamination and assurance of the purity and safety of veterinary vaccines. 
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